The critical role of endothelial function in fine particulate matter-induced atherosclerosis

Shuang Liang; Jingyi Zhang; Ruihong Ning; Zhou Du; Jiangyan Liu; Joe Werelagi Batibawa; Junchao Duan; Zhiwei Sun

doi:10.1186/s12989-020-00391-x

. 2020 Dec 4;17:61. doi: 10.1186/s12989-020-00391-x

The critical role of endothelial function in fine particulate matter-induced atherosclerosis

Shuang Liang ^1,², Jingyi Zhang ^1,², Ruihong Ning ^1,², Zhou Du ^1,², Jiangyan Liu ^1,², Joe Werelagi Batibawa ^1,², Junchao Duan ^1,^2,^✉, Zhiwei Sun ^1,^2,^✉

PMCID: PMC7716453 PMID: 33276797

Abstract

Ambient and indoor air pollution contributes annually to approximately seven million premature deaths. Air pollution is a complex mixture of gaseous and particulate materials. In particular, fine particulate matter (PM_2.5) plays a major mortality risk factor particularly on cardiovascular diseases through mechanisms of atherosclerosis, thrombosis and inflammation. A review on the PM_2.5-induced atherosclerosis is needed to better understand the involved mechanisms. In this review, we summarized epidemiology and animal studies of PM_2.5-induced atherosclerosis. Vascular endothelial injury is a critical early predictor of atherosclerosis. The evidence of mechanisms of PM_2.5-induced atherosclerosis supports effects on vascular function. Thus, we summarized the main mechanisms of PM_2.5-triggered vascular endothelial injury, which mainly involved three aspects, including vascular endothelial permeability, vasomotor function and vascular reparative capacity. Then we reviewed the relationship between PM_2.5-induced endothelial injury and atherosclerosis. PM_2.5-induced endothelial injury associated with inflammation, pro-coagulation and lipid deposition. Although the evidence of PM_2.5-induced atherosclerosis is undergoing continual refinement, the mechanisms of PM_2.5-triggered atherosclerosis are still limited, especially indoor PM_2.5. Subsequent efforts of researchers are needed to improve the understanding of PM_2.5 and atherosclerosis. Preventing or avoiding PM_2.5-induced endothelial damage may greatly reduce the occurrence and development of atherosclerosis.

Keywords: PM_2.5, Endothelial dysfunction, Inflammation, Coagulation, Lipid deposition, Atherosclerosis

Background

The World Health Organization (WHO) reported that approximately 91% of people worldwide live in unhealthy environments where air quality levels exceed WHO limits. The combined effects of indoor and ambient air pollution result in approximately 7 million premature deaths from noncommunicable diseases every year [1]. Chemicals in the air initiate or potentiate a wide range of noncommunicable diseases [2]. Fine particulate matter (PM_2.5, the aerodynamic diameter ≤ 2.5 μm) in air pollution became the fifth death risk factor in 2015 [3]. PM_2.5 is a complex mixture, and its major source is combustion, such as traffic-related diesel exhaust particles (DEPs), industry, indoor cooking activities, and bushfires [4]. For example, the Australian bushfires in 2019-2020 had extreme impacts on air quality throughout the region and even the globally [5]. Thus, the global burden of cardiovascular disease caused by PM_2.5 may be much greater than that previously reported by WHO. Evidence has indicated that PM_2.5 induces lipid metabolism dysregulation and increases hypertension and the prevalence of cardiac arrhythmias, thus accelerating the progression of atherosclerosis, and increasing the risk of cardiovascular disease- and stroke-related mortality [6–9].

Atherosclerosis is a chronic inflammatory disease of large and medium-sized arteries. The causes of atherosclerosis are inflammation, hemodynamic damage and abnormal lipid metabolism in early-stage atherosclerosis [10]. When endothelial cells are activated, they express inflammatory cytokines (such as interleukin (IL)-8, monocyte chemoattractant protein (MCP)-1) and adhesion molecules (such as intercellular adhesion molecule (ICAM-1) and vascular cell adhesion molecule (VCAM-1)), attracting blood monocytes that bind to the activated endothelial monolayer and infiltrate the arterial wall. Important biomarkers of the development of atherosclerotic inflammation include C-reactive protein (CRP), IL-6, adhesion molecules, and matrix metalloproteinases (MMPs) [10]. These factors induce macrophage polarization into the pro-inflammatory M1-like or anti-inflammatory M2-like phenotype [11]. The scavenger receptors of macrophages, such as low-density lipoprotein receptor-related protein 1 (LRP1), cluster of differentiation 36 (CD36) and class B type 1 (SR-B1), play a key role in lipid uptake, deposition and the development of atherosclerotic plaques [12–14]. Liver X receptor α (LXR-α)/ATP-binding cassette transporter A1 (ABCA1)/ABCG1-dependent cholesterol efflux is a crucial event in the suppression of lipid accumulation during the transformation of macrophage foam cells [15]. Vascular smooth muscle cells (VSMCs) migrate from the media to the intima, synthesize extracellular matrix macromolecules such as elastin, proteoglycans and collagen, and form fibrous caps formation. The death of foam cells and VSMCs leads to the release of extracellular lipids in atherosclerotic lesions, leading to the formation of a necrotic core [11, 16]. MMPs (such as MMP-9) are highly expressed in atherosclerotic plaques, leading to substantial enhancement of elastin degradation and inducing plaque rupture [17]. Currently, several imaging techniques can be used to investigate plaques and signs of vulnerability, such as CT, magnetic resonance imaging (MRI) and ultrasound [18]. Molecular imaging is an innovative technique for the detection of plaque inflammation. The utility of several nanoparticles, such as sodium fluoride, iron oxide and polyethylene glycol molecules, for the molecular imaging of atherosclerosis in animal models and patients has been investigated [19–21]. In the past few decades, treatment strategies for atherosclerosis have mainly focused on lowering lipid levels with high-intensity statins. However, only approximately 25% of patients who receive high-intensity statins as a lipid-lowering therapy achieve the recommended level of low-density lipoprotein cholesterol (LDL-C, ≤ 1.8 mmol/L) [22]. Approximately 75% of patients do not respond to statin therapy sufficiently; therefore, novel therapeutic strategies are needed.

PM_2.5 is a complex mixture, and a review had comprehensively summarized the chemical composition and characteristics of PM_2.5, including inorganic elements, water-soluble ions, carbonaceous aerosols and organic compounds (polycyclic aromatic hydrocarbons (PAHs) and volatile organic compounds (VOCs) etc) [4].. A study showed that coal combustion and vehicular emissions are the main sources of PAHs and VOCs in PM_2.5 [23, 24]. Evidence has demonstrated that DEPs accelerate the development or exacerbation of atherosclerosis [25, 26]. Organic chemicals from DEPs, such as PAHs adhere to the carbon cores of particles, and certain PAHs can trigger Ca²⁺ signaling and increase inflammation in endothelial cells [27–30]. Evidence has shown that the levels of urinary PAH biomarkers are associated with cardiovascular disease [31]. Due to the antagonistic and synergic effects of complex VOC mixtures, the toxic effects of VOCs are difficult to estimate [32]. In addition, the surface of particles may bind reactive copollutants, including biomolecules (such as endotoxins), redox-active transition metals, and reactive quinones/aldehydes, which may be carried by particles and enter lung tissue and the circulation, inducing secondary toxicity [33, 34]. The ions and metal components of PM_2.5, including SO₄²⁻, K⁺, Cl⁻, K, Si, As, Zn, Se and Pb, could be mainly responsible for systemic inflammation [35]. Evidence has shown that the binding of endotoxins to the surface of PM_2.5 particles plays a critical role in the inflammatory response. Endotoxin neutralizer (polymyxin B) and knockout of toll-like receptor 4 (TLR4) strongly inhibit the PM_2.5-triggered inflammatory response [36]. However, the understanding of the major toxic effects exerted by the specific components of PM_2.5 is limited. Further investigating the toxicity of PM_2.5 components will contribute to a comprehensive understanding of PM_2.5, which may be a key area of future research.

Endothelial cells cover the internal surface of blood vessels, and the integral endothelial cell layer maintains a complex functional balance to inhibit the inflammatory response or thrombosis. Ambient PM_2.5 exposure elicits the deterioration of endothelial function, systemic inflammation and coagulation [37, 38]. Evidence has shown that a 10 μg/m³ increase in the PM_2.5 concentration at a 1-day lag was associated with increased brachial-ankle pulse wave velocity (baPWV, a physiological indicator of arterial stiffness), but not with high-sensitivity C-reactive protein (hsCRP, a biomarker of vascular inflammation) levels; thus, arterial stiffness might be more sensitive to ambient PM_2.5 exposure than inflammation [39]. Accordingly, indoor PM_2.5 also induces endothelial dysfunction and inhibits blood vessel formation but has no significant association with arterial stiffness [40, 41]. Endothelial dysfunction disrupts anti-inflammatory processes, anti-platelet aggregation, anti-thrombotic processes and vascular repair in vivo [42]. Alterations in vascular function might be the earliest pathophysiological mechanism contributing to air pollution-mediated cardiovascular diseases, and indeed, such changes are a critical early predictor of atherosclerosis [43, 44]. However, there is a lack of systematic understanding of the mechanism of PM_2.5-induced endothelial dysfunction. Moreover, a review focused on scientific evidence that DEPs induce endothelial dysfunction, including bioavailability and mechanisms, and is related to cardiovascular injury [45].

Therefore, this review mainly provides an overview of the literature related to PM_2.5 and atherosclerosis, and discusses the mechanism of PM_2.5-induced vascular endothelial injury. Approximately 30% of ambient PM_2.5 is attributable to traffic sources [46–48]. Thus, we also review evidence for the role DEPs in atherosclerosis and endothelial dysfunction in this review. Fig. 1 summarizes the main mechanisms of PM_2.5-triggered atherosclerosis. We review the main mechanisms of endothelial dysfunction after exposure to ambient or indoor PM_2.5. Furthermore, we discuss the role of ambient PM_2.5-induced vascular endothelial injury in the development of atherosclerosis. Targeting endothelial injury, as the initial pathological process of atherosclerosis, is the key to preventing the occurrence of atherosclerotic cardiovascular disease. Therefore, a scientific understanding of the mechanism of PM_2.5-induced endothelial dysfunction will play a critical role in the prevention and treatment of atherosclerosis and other cardiovascular-related diseases.

PM_2.5 and atherosclerosis

As shown in Fig. 1, four main hypotheses by which inhaled particulate matter affects the cardiovascular system have been proposed: a. Inhaled particulate matter reaches the terminal bronchioles and enters alveoli, inducing an inflammatory response in the lung; b. Released inflammatory mediators and unidentified mediators enter the circulation; c. A small proportion of particles reach the circulation; and d. Inhaled particulate matter activates alveoli sensory receptors, leading to autonomic imbalance [49]. Fig. 1 summarizes the main mechanisms of PM_2.5-triggered atherosclerosis. Endothelial injury increases the release of IL-6, VCAM-1, ICAM-1, and other inflammatory cytokines, recruiting blood monocytes that bind to the activated endothelial monolayer. The bound monocytes migrated directly into the intima and mature into macrophages. PM_2.5 increases the expression of CD36 in plaque macrophages and mediates the abnormal accumulation of oxidized lipids (such as 7-ketocholesterol, 7-KCh), finally promoting foam cell formation [12]. TLR4 recognizes modified lipoprotein, which mediates lipoprotein accumulation in macrophages [50]. Jin Geng et al. showed that PM_2.5 can trigger foam cell formation via the TLR4/MyD88/NF-κB pathway [51]. Oxidized low-density lipoprotein (ox-LDL) primes and activates the NOD-like receptor protein 3 (NLRP3) inflammasome by binding to TLR4 or CD36 in macrophages and increases the release of inflammatory cytokines (IL-1β and IL-18) and pyroptosis [11]. PM_2.5 induces oxidative stress, increasing the apoptosis of foam cells via the mitochondrial apoptosis pathway [52]. PM_2.5 impairs HDL functions such as HDL-mediated cholesterol efflux, thus facilitating foam cell formation and accumulation [53]. Apoptotic cells are not quickly and efficiently engulfed and decomposed by phagocytes, resulting in secondary necrosis and the release of a large amount of pro-inflammatory cytokines and thus contributing to the development of the necrotic core [54]. However, currently, there is a lack of evidence concerning the efferocytosis of phagocytes in atherosclerosis induced by PM_2.5. In addition, oxidative stress induced by PM_2.5 can increase the proliferation and foam cell formation in VSMCs; however, future research is required to demonstrate the role of oxidative stress in mediating PM-triggered foam cell formation [55, 56]. VSMCs migrate from the media to the intima and synthesize extracellular matrix macromolecules such as elastin, proteoglycans and collagen, and fibrous cap formation. However, reports concerning the migration of VSMCs triggered by PM_2.5 are lacking. The death of foam cells and the release of extracellular lipids in atherosclerotic lesions lead to the formation of a necrotic core [11, 16].

Table 1 summarizes epidemiological studies on the association between PM_2.5 exposure and atherosclerosis. One of the major sources of ambient PM_2.5 is traffic-derived emissions. Traffic noise is an important confounding factor in the effects of air pollutant exposure from traffic, and evidence has demonstrated that night-time traffic noise and PM_2.5 are both associated with a 3.9% (95% CI: 0.0 - 8.0%) increase in thoracic aortic calcification (TAC)-burden per 5 dB(A) night-time traffic noise and an 18.1% (95% CI: 6.6 - 30.9%) increase in TAC burden per 2.4 μg/m³ PM_2.5. Importantly, both are independently associated with the development and progression of subclinical atherosclerosis [59, 71]. Carotid intima-media thickness (CIMT) is defined as the distance between the lumen-intima and media-adventitia borders of the common carotid artery and can be measured by vascular ultrasound; an increase in the CIMT is a marker of subclinical atherosclerosis [93]. PM_2.5 exposure is associated with an increase in the CIMT; moreover, increased or slowed CIMT progression is associated with PM_2.5 concentration [68]. The PM_2.5 components sulfur, elemental carbon (EC) and organic carbon (OC), but not silicon, are associated with increased CIMT, and OC has the strongest association [69, 78]. Long-term exposure to PM_2.5 can increase systematic inflammation, the levels of fibrofatty and necrotic core components, and total plaque volume [38, 79]. Short-term exposure to PM_2.5 is associated with inflammation, coagulation, endothelial activation and ox-LDL levels [38, 63]. Table 2 summarizes animal studies of PM_2.5-induced atherosclerosis. PM_2.5 promotes the progression of advanced atherosclerotic lesions. Concentrated ambient PM_2.5, rather than whole diesel exhaust and diesel exhaust gases, is mainly responsible for plaque exacerbation [99]. However, an improved understanding of which components of PM_2.5 induce or promote the development of atherosclerosis, which may be a direction of future research, is needed. Mechanistically, changes in oxidative stress, systematic inflammation and lipid metabolism are the most common mechanisms of PM_2.5-induced atherosclerosis. The mechanisms of atherosclerosis induced by PM_2.5 have been reviewed [105]. Oxidative stress induced by particulate matter may be key to triggering the development of atherosclerosis, coagulation and thrombosis [106, 107]. Endothelial dysfunction is a critical initiating event that promotes the development of atherosclerosis. However, a systematic understanding of the mechanisms underlying PM_2.5-induced endothelial dysfunction leading to atherosclerosis is lacking.

Table 1.

Epidemiological studies on the association between PM_2.5 exposure and atherosclerosis

Reference	Location	Study design	Sample size	Pollutants	PM_2.5 Exposure	Evaluation index	Findings or association
[57]	-	Meta-analysis	9183	Ambient PM_2.5, PM₁₀, PM_2.5abs, PMcoarse, NOx, NO₂	-	CIMT	PM_2.5 (per 5 μg/m³ increase): CIMT increased by 0.78% (95% CI: -0.18%, 1.75%, p = 0.11).
[58]	Ohio, United States	Prospective longitudinal cohort	6575	Ambient PM_2.5, NO₂	Long-term exposure	Angiography	PM_2.5 (per 2.2 μg/m³ increase): Mild coronary atherosclerosis (defined as 1 to 2 vessels with ≥ 50% stenosis) OR = 1.43 (95% CI: 1.11-1.83; p = 0.005); Severe coronary atherosclerosis (defined as 3 vessels with ≥ 50% stenosis) OR = 1.63 (95% CI: 1.26 to 2.11; p < 0.001).
[59]	CA, USA	Cross-sectional	4238	PM_2.5, traffic noise	Long-term exposure	TAC	PM_2.5 (per 2.4 μg/m³ increase): TAC burden increased by 18.1% (95% CI: 6.6 to 30.9%).
[60]	USA	Longitudinal cohort	6814	Ambient PM_2.5 NOx, NO₂ and black carbon	Long-term exposure	CAC; IMT	PM_2.5 (per 5 μg/m³ increase): Coronary calcium progressed by 4.1 Agatson units per year (95% CI: 1.4 to 6.8); Without association with IMT, -0.9 μm per year (95% CI: -3.0 to 1.3).
[61]	India	prospective, intergenerational cohort	3278	Ambient and indoor air pollution	Long-term exposure	CIMT	Ambient PM_2.5 (per 1 μg/m³ increase): CIMT increased by 1.79% (95% CI: -0.31 to 3.90) in all participants; CIMT increased by 2.98% (95% CI: 0.23 to 5.72) in men. Indoor air pollution (biomass cooking fuel): CIMT increased by 1.60% (95% CI: -0.46 to 3.65) in all participants
[62]	-	Meta-analysis	-	PM_2.5	-	CIMT arterial calcification; ankle-brachial index	PM_2.5 (per 10 μg/m³ increase): CIMT increased by 22.52 μm (p = 0.06); Without association with arterial calcification (p = 0.44) or ankle-brachial index (p = 0.85).
[63]	USA	Cross-sectional	6654	Ambient PM_2.5 and black carbon	12 months, 3 months 2 weeks Short-term exposure (0-5 days)	HDL-C HDL particle number	No significant association between PM_2.5 and HDL-C; PM_2.5 (per 5 μg/m³ increase) exposure for 3 months: HDL-P decreased by 0.64 μmol/L (95% CI: -1.01 to -0.26); PM_2.5 (per 5 μg/m³ increase) exposure for 2-week: HDL-C increased by -0.86 mg/dL (95% CI: -1.38 to -0.34); HDL-P decreased by 0.29 μmol/L (95% CI: -0.57 to -0.01). PM_2.5 (per 5 μg/m³ increase) exposure for 5 days: HDL-P decreased by 0.21 μmol/L (95% CI: -0.38 to -0.04).
[64]	Beijing, China	Panel study	40	Ambient PM_2.5	Short-term exposure (1 day)	Ox-LDL; sCD36	PM_2.5 chloride, strontium, iron (1-day, per 0.51 μg/m³ increase) and nickel (2-day, 2.5 μg/m³ increase): ox-LDL increased by 1.9% (95% CI: 0.2% to 3.7%, p < 0.05) and 1.8% (95% CI: 0.2% to 3.4%), respectively; PM_2.5 calcium (1-day, 0.7 μg/m³ increase): sCD36 increased by 4.8% (95% CI: 0.7% to 9.1%).
[65]	Beijing, China	Cross-sectional	8867	Ambient PM_2.5, NO₂, O₃	Long-term exposure	CAC Score	PM_2.5 (per 30 μg/m³ increase): CAC scores increased by 27.2% (95% CI: 10.8% to 46.1%); CAC increased by 42.2% (95% CI: 24.3% to 62.7%) in men, 50.1% (95% CI: 28.8% to 75%) in elderly participants, 62.2% (95% CI: -1.4% to 20.4%) in those with diabetes.
[66]	Taiwan	Cross-Sectional	689	Ambient PM₁₀, PM_2.5, PM_2.5abs, NO₂, NOx	Long-term exposure	CIMT	PM_2.5abs (per 1.0 x 10^-5/m): Maximum left CIMT increased by 4.23% (95% CI: 0.32% to 8.13%, p < 0.05); PM_2.5 mass concentration was not associated with CIMT.
[67]	Toronto	Cohort study	30	Urban PM_2.5 and O₃	Short-term exposure (2 h)	HOI; Blood pressure;	PM_2.5 (exposure for 2h, 1h after exposure): Association with HOI (p = 0.078); HOI associated with systolic blood pressure (p = 0.05).
[68]	USA	Cross-sectional, longitudinal	5276	PM_2.5	Long-term exposure	CIMT	PM_2.5 concentration (per 2.5 μg/m³ increase): Increased IMT progression (5.0 μm/y, 95% CI: 2.6 to 7.4 μm/y); PM_2.5 concentration (per 1 μg/m³ reduce): Slowed IMT progression (-2.8 μm/y, 95%CI: -1.6 to -3.9μm/y).
[69]	USA	Cross-sectional	5488	Ambient PM_2.5	Long-term exposure	CIMT	PM_2.5 (sulfur, silicon, EC and OC): Association: CIMT Sulfur (0.022 mm, 95% CI: 0.014 to 0.031); silicon (0.006 mm, 95% CI: 0.000 to 0.012); OC (0.026 mm, 95% CI: 0.019 to 0.034).
[70]	South India	Cross-sectional	7000	PM_2.5	-	CIMT	PM_2.5 (per 1 μg/m³ increase): Association: CIMT.
[71]	Germany	Cohort study	4814	Traffic- related air pollution and noise	Long-term exposure	TAC	No associations between PM_2.5 and TAC
[72]	USA	Longitudinal	165675	Ambient PM (PM₁₀, PM_2.5, PM_2.5-10)	Long-term exposure; Short-term exposure	Leukocyte Counts and Composition	PM_2.5 (per 10 μg/m³ increase, exposure for 1-month): Increased: leukocyte count (12 cells/μl, 95%CI: -9 to 33), granulocyte proportion (1.2%, 95% CI: 0.6% to 1.8%); Decreased: CD8⁺ T cell (-1.1%, 95%CI: -1.9% to -0.3%); PM_2.5 (per 10 μg/m³ increase, exposure for 12-month): Increased: leukocyte count (28 cells/μl, 95%CI: -20 to 75), granulocyte proportion (1.1%, 95% CI: -0.2% to 2.4%); Decreased: CD8⁺ T cell (-1.3%, 95%CI: -2.4% to -0.1%);
[38]	USA	Longitudinal	6814	Ambient PM_2.5	Long-term exposure; Short-term exposure	Serum CRP, IL-6, fibrinogen, D-dimer, soluble E-selectin, sICAM -1	Long-term exposure to PM_2.5 ( per 10 μg/m³ increase): Association: inflammation and fibrinolysis (CRP, fibrinogen and E-selectin); Increased: e.g. IL-6 (6%, 95%CI: 2% to 9%). Short-term exposure to PM_2.5: Association: inflammation, coagulation and endothelial activation.
[73]	Netherlands	Prospective cohort	750	Air pollutants (PM_2.5, NO₂, black smoke, SO₂)	Long-term exposure	CIMT; PWV; AIx	PM_2.5 (per 5 μg/m³ increase): CIMT increased by 0.94% (95% CI: -.2.59% to 4.47%); PWV increased by 0.64% (95% CI: -4.71% to 6.01%); AIx increased by 10.17% (95% CI: -37.82% to 58.17%);
[74]	USA	Cohort study	3996	PM_2.5, PM₁₀	Long-term exposure	radial artery pulse wave and carotid artery ultrasound	Long-term particle mass exposure: Not appear to be associated with greater arterial stiffness.
[75]	Australian	Cross-sectional	606	Ambient PM_2.5, NO₂	Long-term exposure	CCS	PM_2.5 (per μg/m³ increase): Association: CCS (≥ 100): (OR 1.20, 95% CI: 1.02 to 1.43); CCS (≥ 400): (OR 1.55, 95% CI: 1.05 to 2.29).
[76]	Germany	Cross-sectional	4291	Ambient PM_2.5, PM₁₀	Long-term exposure	Arterial blood pressure (BP)	Per IQR of PM_2.5 (2.4 μg/m³): Systolic BP increased by 1.4 mmHg (95% CI: 0.5 to 2.3); Diastolic BP increased by 0.9 mmHg (95% CI: 0.4 to 1.4).
[77]	Switzerland	Cross-sectional	1503	Ambient PM₁₀, PM_2.5, UFP	Long-term exposure	CIMT	Vehicular source of PM_2.5: CIMT increased by 1.67% (95% CI: -0.30 to 3.47%).
[78]	USA	Cross-sectional	6256	Ambient PM_2.5 (EC, OC, silicon, and sulfur)	Long-term exposure	CIMT, PM_2.5 components EC, OC, silicon, and sulfur	Per IQR increase of PM_2.5: Association/increase: CIMT PM_2.5 (14.7 μm, 95% CI: 9.0 to 20.5); OC (35.1 μm, 95% CI: 26.8 to 43.3); EC (9.6 μm, 95% CI: 3.6 to 15.7); Sulfur (22.7 μm, 95% CI: 15.0 to 30.4).
[79]	Seoul, Korea	Cohort study	364	Ambient PM_2.5	Long-term exposure	Coronary computed tomographic angiography	PM_2.5 (per 1 μg/m³ increase): Increase/association: HRP (aHR 1.62, 95% CI: 1.22 to 2.15, p < 0.001); fibrofatty and necrotic core component (aHR 1.41, 95% CI: 1.23 to 1.61, p < 0.001); total plaque volume progression (aHR 1.14, 95% CI: 1.05 to 1.23, p = 0.002).
[80]	USA	Cross-sectional	417	Ambient PM_2.5,O₃	Long-term exposure	CIMT	PM_2.5 (per 1 μg/m³ increase): CIMT increased by 4.28 μm/y (95% CI: 0.02 to 8.54μm/y).
[81]	Germany	Prospective cohort	4494	Traffic and PM_2.5	Long-term exposure	CAC	Possible association between PM_2.5 exposure and CAC
[82]	USA	Cohort study	3506	Ambient PM_2.5	Long-term exposure	TAC, AAC	No consistent associations between PM_2.5 and TAC, AAC
[83]	Taiwan	Prospective cohort	30034	Ambient PM_2.5	Long-term exposure	CRP	PM_2.5 (per 5 μg/m³ increase): Association: systemic inflammation CRP increased by 1.31% (95% CI: 1.00% to 1.63%)
[84]	North Carolina	Cross-sectional	861	PM₁₀, PM_2.5, NO₂, O₃	-	CIMT	No associations between PM_2.5 and CIMT.
[85]	Detroit, MI; Oakland, CA; Pittsburgh, PA; Chicago, IL; and Newark, NJ	Cohort study	1188	PM_2.5, O₃	Long-term exposure	CIMT, IAD, plaque presence and plaque index	PM_2.5 (1 μg/m³ higher 5-year mean): CIMT increased 8 μm (95% CI: 1.0 to 15.1), adjusting for cardiovascular disease risk factors; No significant associations between PM_2.5 and IAD; No associations between PM_2.5 and plaque presence or plaque index.
[86]	German	Cohort study	4814	PM_2.5, PM₁₀	Long-term exposure	CIMT	PM_2.5 (interdecile range increase 4.2μg/m³): CIMT increased 4.3% (95% CI: 1.9% to 6.7%); PM₁₀ (interdecile range increase 6.7μg/m³): CIMT increased 1.7% (95% CI: -0.7% to 4.1%).
[87]	Sichuan, China	Longitudinal study	205	Household air pollution (PM_2.5 and BC)	Short-term exposure (48 h)	BP, PP, cfPWV, AIx	PM_2.5 (1-ln (μg/m³) increase): Association: SBP; PP; cfPWV (-0.1 m/s, 95% CI -0.4 to 0.2) with no difference; slightly higher AIx (1.1%, 95% CI -0.2 to 2.4).
[88]	Puno, Peru	Cross-sectional	266	Householdbiomass fuel	long-term exposure	Measure 24 h indoor PM_2.5, CIMT, Carotid plaque, BP	Biomass fuel exposure: Increased: CIMT (0.66 vs 0,60 mm, p < 0.001); carotid plaque prevalence (26% vs 14%, p < 0.05); systolic BP (118 vs 111 mm Hg, p < 0.001); median household PM_2.5 (280 vs 14 μg/m³, p < 0.001).
[39]	Taiwan, China	Prospective panel atudy	117	Ambient PM_2.5, NO₂	-	baPWV, hsCRP	PM_2.5 (10 μg/m³ increases at 1 day lag): Association: baPWV (2.1%, 95% CI: 0.7%-3.6%; 2.4%, 95% CI: 0.8%-4.0%); No significant association between NO₂ and baPWV.
[89]	USA	Cross-sectional	798	PM_2.5	long-term exposure	CIMT	PM_2.5 (10 μg/m³ increases): CIMT increased (5.9%, 95% CI: 1 to 11%); Adjustment of age, never smokers, ≥ 60 years of age women: the strongest associations with CIMT increased (15.7%, 95% CI: 5.7 to 26.6%).
[90]	USA	Cross-sectional	1147	PM_2.5	long-term exposure	calcium scores	PM_2.5 (10 μg/m³): Aortic calcification (RR=1.06; 95% CI: 0.96 to 1.16); Long-term residence near a PM_2.5 monitor (RR=1.10; 95% CI: 1.00 to 1.22).
[91]	USA	Cohort study	5172	PM_2.5	long-term exposure	CIMT	PM_2.5 (12.5 μg/m³ increases): CIMT increased 1 to 3%.
[81]	Geman	Prospective cohort study	4494	PM_2.5	long-term exposure	CAC	PM_2.5 (3.91 μg/m³): CAC higher 17.2% (95% CI: -5.6 to 45.5%).
[92]	Hebei, China	Cross-sectional	752	Indoor PM_2.5, CO, SO₂	Long-term exposure	CIMT, IL-8, CRP, TNF-α, SAA1	Smoky coal combustion-derived indoor air pollutants: Increased: systemic inflammation; The risk of carotid atherosclerosis RR = 1.434 (95% CI: 1.063 to 1.934, p = 0.018).

Open in a new tab

Note: Short-term exposure means the period of exposure is less than 3 months; Long-term exposure means the period of exposure is longer than 3 months

AAC abdominal aortic calcium agatston score, aHR adjusted hazard ratio, AIx augmentation index, BC black carbon, BP Blood pressure, CAC coronary artery calcification, CCS Coronary artery calcium score, cfPWV carotid-femoral PWV, CI confidence interval, CIMT carotid intima-media thickness, CRP C-reactive protein, EC elemental carbon, HDL-P high-density lipoprotein cholesterol particle matter, HOI HDL oxidant index, HDL-C high-density lipoprotein cholesterol, HRP high-risk plaque, IAD inter-adventitial diameter, IMT intima-media thickness, IL interleukin, O₃ ozone, IQR interquartile, NO nitrogen dioxide, OC organic carbon, Ox-LDL oxidized low-density lipoprotein, OR odds ratio, PM_2.5abs absorbance levels of PM_2.5, PNacc particle number of accumulation mode particles, PP pilse pressure, UFP ultrafine particles (< 0.1μm), TAC thoracic aortic calcium agatston score, SBP systolic blood pressure, sCD36 soluble cluster of differentiation 36, sICAM-1 soluble Intercellular Adhesion Molecule-1, SO₂ sulfur dioxide, PWV Pulse wave velocity, baPWV brachial-ankle pulse wave velocity

Table 2.

Animal studies on the association between PM_2.5 exposure and atherosclerosis

Reference	PM_2.5 source	Mouse model	Diet	Exposure Time	Findings
[94]	Shanghai, China Ambient PM_2.5	ApoE^-/- mice	Normal chow; High-fat diet	8 h/day, 7 days/week, 16 weeks	PM_2.5 exposure induced and promoted atherosclerotic lesions with significant difference. Increased: Atherosclerotic plaque; lipids (ApoB, LDL-C, T-CHO, TG); CD36; ox-LDL; inflammatory cytokines (IL-1β, IL-18); NLRP3, caspase-1, ASC, pro-caspase-1, cleaved-caspase-1; Decreased: Lipids (ApoA1 and HDL-C)
[95]	Nanjing, China Ambient PM_2.5	ApoE^-/- mice	High-fat diet	12 weeks	PM_2.5 exposure amplified atherosclerotic lesions with significant difference. Increased: Atherosclerotic plaque; lipid accumulation; TC; LDL-C; Inflammatory cytokines (IL-6, TNF-α); Deceased: Anti-inflammatory cytokines (IL-10, TGF-β); CD4⁺CD25⁺Foxp3⁺Tregs; Foxp3
[96]	Beijing, China Ambient PM (PM_2.5 and PM₁₀)	ApoE^-/- mice	High-fat diet	24 h/day, 7 days/week, 2 months	PM_2.5 increased atherosclerotic plaque with significant difference. Increased: Lesion area; TC; LDL; ox-LDL; visfatin; systemic inflammation and pulmonary inflammation response (IL-6, TNF-α); MDA Decreased: SOD; GSH-Px
[97]	Beijing, China Ambient PM (PM_2.5 and PM₁₀)	ApoE^-/- mice	High-fat diet	24 h/day, 7 days/week, 2 months	PM_2.5 exposure increased atherosclerotic plaque with significant difference. Increased: Plaque area; TC; LDL; ox-LDL; systemic inflammation (Hs-CRP, IL-6, TNF-α) and pulmonary inflammation response (IL-6, TNF-α); Decreased: T-AOC; SOD
[12]	Michigan State University, USA Ambient PM_2.5	ApoE^-/- or LDLR^-/- mice	High-fat diet	6 h/day, 5 days/week, 6 months	PM_2.5 exposure increased atherosclerotic plaque with significant difference. Increased: Lesion area; lipid and collagen content; 7-KCh and uptake; CD36; foam cell formation
[51]	Nanjing, China Ambient PM_2.5	ApoE^-/- mice	High-fat diet	twice/week, 12 weeks or 24 weeks	PM_2.5 exposure promoted atherosclerotic plaque development and increased plaque vulnerability, with significant difference. Increased: Lesion area, lipid; broken aortic elastic fibers; Decreased: Collagen content; fibrous cap
[6]	Beijing, China Ambient PM_2.5	ApoE^-/- mice	High-fat diet	Every 3 days, 2 months,	PM_2.5 exposure increased the formation of atherosclerosis and the influence probably persisted after 1-month recovery, with significant difference. Increased: Atherosclerotic lesion; inflammatory cytokines; lipid metabolism alteration.
[98]	Tianjin, China Traffic related PM_2.5, simulated PM_2.5	ApoE^-/- mice	High-fat diet	Every two days, 10 weeks	Traffic related and simulated PM_2.5 promoted the formation of atherosclerosis with significant difference. Increased: Plaque; T-CHO; LDL-C; TG; MDA; Decreased: HDL-C; SOD; GSH-Px
[99]	Northeastern, China Ambient PM_2.5, WDE, DEG	ApoE^-/- mice	Normal chow	average of 5.2 hours/day, 4 days/week, 3 months and 5 months	Exposure to PM_2.5 for 5 months induced atherosclerotic plaques with significant difference. For plaque exacerbation, PM_2.5 > WDE > DEG = FA Increased: Plaque; vasomotor dysfunction; inflammation
[100]	Yinchuan, China coal-fired PM_2.5	C57BL/6J mice and ApoE^-/- mice	High-fat diet	3 h/day, 1 day/week, 8 weeks	Coal-fired PM_2.5 significantly promoted the formation atherosclerosis with significant difference. Increased: Plaque; foam cells; fibrous cap formation; ET-1; ICAM-1; E-selectin Decreased: vWF
[101]	Manhattan, USA PM_2.5	ApoE^-/- mice	Normal chow and High-fat diet	6 h/day, 5 day/week, 6 months	In high-fat diet group, PM_2.5 increased plaque area compared with FA (p < 0.01); In normal chow group, PM_2.5 increased plaque area compared with FA (p < 0.15). Increased: Plaque area; Cholesterol; Constriction response; CD68; 3-Nitrotyrosine; eNOS; iNOS; Decreased: Relaxation response
[102]	Los Angeles freeway, USA PM_2.5	ApoE^-/- mice	regular diet	5 h/day, 3 day/week, 75 hours	PM_2.5 resulted in aortic atherosclerotic lesion increased trend (p = 0.1). Increased: Plaque area; Liver MDA; Decreased: HDL anti-inflammatory properties
[103]	New York; USA PM_2.5	C57BL/6, ApoE^-/- mice, ApoE and LDLR double knockout (DK)	High-fat diet and regular diet	6 h/day, 5 day/week, 5 months	PM_2.5 exposure increased atherosclerotic lesion in ApoE^-/- mice (p < 0.05). Atherosclerotic lesion 57% increase in ApoE^-/- mice; Atherosclerotic lesion 10% increase in male DK mice and 8% decrease in female DK mice.
[104]	New York; USA PM_2.5	ApoE^-/- mice	High-fat diet	30 mg/kg/day, 8 weeks	PM_2.5 contributed to the progression of atherosclerosis (p < 0.05). Increased: Atherosclerotic plaques; numbers of lesion macrophages; endothelial layer injury; platelets and leukocytes adherence; IL-6; TNF-α; iNOS; IL-12; arginase-1; CD206
[26]	DEP, 1650b, NIST, USA	C57BL/6, ApoE^-/- mice	Regular chow or high-fat diet	Once a day during 5 days/week, 3-6 weeks	DEP exposure increased atherosclerotic lesion in ApoE^-/- mice (p < 0.05). Increased: Atherosclerotic plaques; EPC apoptosis; superoxide production; Decreased: Neoangiogenesis; EPC migration; Endothelial cell interity
[25]	DEP, SRM-2975, NIST, USA	C57BL/6, ApoE^-/- mice	Regular chow or high-fat diet	Twice weekly instillation	DEP exposure increased atherosclerotic lesion in ApoE^-/- mice (p < 0.05). Increased: Atherosclerotic plaques; Cholesterol; antioxidant genes in the liver

Open in a new tab

Note: Apo A1 apolipoprotein A1, Apo B apolipoprotein B, ASC apoptosis associated speck like protein, CD36 cluster of differentiation 36, DEG diesel exhaust gases, DEP Diesel exhaust particles, ET-1 endothelin-1, eNOS endothelial nitric oxide synthase, FA filtered air, Foxp3 forkhead box transcription factor P3, GSH-Px glutathione peroxidase, HDL-C high density lipoprotein-cholesterol, Hs-CRP high sensitive C-reactive protein, IL interleukin, ICAM-1 Intercellular Adhesion Molecule-1, iNOS inducible nitric oxide synthase, 7-KCh 7-ketocholesterol, LDL-C low density lipoprotein-cholesterol, MDA malondialdehyde, NIST National Institute of Standards and Technology, NLRP3 NOD-like receptor protein 3, ox-LDL oxidized low-density lipoprotein, PM particulate matter, SOD superoxide dismutase, T-AOC total antioxidant capacity, T-CHO total cholesterol, TG triglycerides, TGF-β transforming growth factor-β, TNF-α tumor necrosis factor α, vWF von willebrand factor, WDE whole diesel exhaust

Ambient PM_2.5 induces endothelial dysfunction

The endothelial cell monolayers of blood vessels play a role in exchanging macromolecules between the blood and tissues. Mechanical stimuli such as shear stress, inflammatory cytokines and angiotensin-II (Ang-II) affect endothelial permeability [108, 109]. We concentrated on studies indicating that PM_2.5 impacts vascular endothelial dysfunction. Many studies have demonstrated that PM_2.5 increases the vascular permeability, impairs endothelial vasomotor function and vascular reparative capacity via different mechanisms and occurs before vascular diseases such as atherosclerosis. Traffic-derived emissions are a major source of ambient PM_2.5; therefore, literature on the toxicity of traffic emissions (mainly DEPs) on blood vessels and endothelial cells and the similarities between PM_2.5 and DEPs are also discussed in this review. The effects of PM_2.5 and DEPs on endothelial cells are shown in Table 3. In brief, the existing evidence shows that PM_2.5 and DEPs both consistently induces endothelial cytotoxicity through similar mechanisms, such as by increasing endothelial cellular apoptosis via oxidative stress or autophagy, reducing the migration of endothelial cells and enhancing vascular endothelial permeability [111, 117, 118, 122, 123]. The detailed mechanisms of endothelial cytotoxicity induced by PM_2.5 or traffic-derived pollutants are discussed below. In addition, coal-fired PM_2.5 also decreases endothelial viability; however, the detailed mechanisms are limited to increases in DNA methylation and oxidative DNA damage in EA.hy926 cells [128].

Table 3.

PM_2.5 exposure in endothelial cells

Reference	Endothelial cells lines	PM_2.5 source	Exposure concentration	PM_2.5 Exposure time	Evaluation
[110]	EA.hy926	Beijing, China Urban PM_2.5	PM_2.5: 2, 10, 40, 100, 200, 1000 μg /cm²; SOD (ROS scavenger): 0.5 mg/ml.	24 h	Trace elements in PM_2.5 suspension, water-insoluble and water-soluble; Cell viability; ROS; MMP; Apoptosis.
[111]	EA.hy926, HUVECs	PM_2.5 SRM1648a, NIST, USA	PM_2.5: 1.25, 2.5, 5, 10, 20, 40 μg /cm²; 4-PBA (ER stress inhibitor): 1 mM; 3-MA (a classical PI3K III inhibitor, autophagy antagonist): 2.5 mM; Rapa (an mTOR inhibitor, autophagy agonist): 50 nM; Bafi A1 (a proton-pump inhibitor, autolysosome inhibitor): 20 nM.	24 h	Cell viability; ER stress; Autophagy; Apoptosis; Autophagic flux.
[112]	EA.hy926, HUVECs	PM_2.5 SRM1648a, NIST, USA	PM_2.5: 1.25, 2.5, 5, 10, 20, 40 μg/cm²; Fer-1 and DFOM (ferroptosis inhibitors): 500 nM and 5 μM, respectively.	24 h or 12 h	Cell viability; intracellular iron content; GSH; lipid peroxidation; redox imbalance; ferroptosis-related genes or biomarkers.
[113]	PCAECs	Fine dust, ERM-CZ100, Sigma-Aldrich, USA	Fine dust: 1, 3, 10, 30, 100 μg/ml; NAC: 10 mM; Losartan: 10 μM.	48 h or 1, 4, 24 h	SA-β-gal; platelet aggregation; cell proliferation; Oxidative stress; Relaxation; Senescence.
[114]	HUVECs	Beijing, China	PM_2.5: 2, 20, 100 μg/ml; NAC: 5 mmol/l	6, 12, 24 h	VE-cadherin; VEGFR2 and MAPK/ERK signaling; ROS; SOD.
[108]	HUVECs	Beijing, China	PM_2.5: 80 μg/ml; miR-21 inhibitor	24 h	miR-21; target genes; VE-cadherin.
[115]	HUVECs	Mexico	PM_2.5: 20 μg/cm²;	3, 24, 48, 72 h	Oxidative stress; NF-κB; Apoptosis.
[116]	HUVECs	Wuhan, China	PM_2.5: 6.25, 12.5, 25 μg/ml; SP600125 (JNKs inhibitor); SB203580 (p38K inhibitor); PD98059 (ERKs inhibitor);	24 h	AP-1; Oxidative stress; pro-inflammatory response.
[117]	HUVECs, HMEC-1	PM_2.5 NIST, USA	PM_2.5: 100, 200, 400, 800 μg/ml;	24 h	Cell viability; Apoptosis; Migration; Tube formation; ROS; Inflammation.
[118]	EA.hy926	Yuquan Road, Beijing, China	PM_2.5: 25, 50, 100, 200 μg/ml; SP600125 (JNK inhibitor): 25 μM; U0126 (ERK inhibitor): 10μM; SB203580 (p38 MAPK inhibitor): 25μM; LY294002 (PI3K/AKT inhibitor): 25μM; BAY11-7082 (NF-kB inhibitor): 5μM.	1, 3, 6, 12, 24 h	Cell viability; ROS; Adhesion molecule; Adhesion experiment.
[119]	HUVECs	COFs-derived PM_2.5	PM_2.5: 12.5, 25, 50, 75, 100, 200μg/ml; SU5416 (a VEGFR2 inhibitor): 0.5, 1, 2.5, 5, 7.5, 10, 20 μM.	12, 24, 36 h	Cell viability; Tube formation.
[120]	HUVECs	Taiyuan, China	PM_2.5: 1, 5, 10 μg/ml; Pam3CSK4 (TLR2 agonist): 1μg/ml; LPS (TLR4 agonist): 500μg/ml; anti-TLR2 (TLR2 inhibitor): 10μg/ml; TAK242 (TLR4 inhibitor): 5μmol/l.	12 h	Inflammation.
[121]	MAECs	Wuhan, China	PM_2.5: 25, 50, 100 μg/ml; NS-398 (COX-2 inhibitor): 10μM.	12, 24 h	Apoptosis.
[122]	HUVECs, ATG12-KO HUVECs	Diesel exhaust particles (DEP)	DEP: 25, 50 μg/ml; NAC: 5 mM; Nutllin-3a: 5 μM; PMA (ROS inducer): 1μM	2, 4, 8, 24 h	Cell viability; ROS; Cytokeleton; Lysosome; Apoptosis; DNA damage; Tube formation; Migration; Autophagy.
[123]	HAECs	DEP	DEP: 12.5, 25, 50μg/ml;	2, 4, 6 h	Permeability; LDH; Apoptosis; ZO-1.
[124]	HUVECs	Non-industry district, Shanghai, China	PM_2.5: 100, 200, 400 μg/ml; Atorvastatin: 0.1, 1, 10 μmol/l.	24 h	Water-soluble and organic extracts; Cell viability; Oxidative stress; Cytokines.
[125]	HCAECs	Southern Taiwan	PM_2.5: 20, 50 μg/ml;	4 h	Metal fume particles; Cell viability; 8-OHdG; IL-6; NO.
[126]	HUVECs	Mexico	PM_2.5: 5, 10, 20, 40 μg/cm²; TNF-α: 10 ng/ml.	6 or 24 h	Cell viability; Adhesion; Adhesion molecules.
[127]	HUVECs	Beijing, China	PM_2.5: 5, 25, 50, 100, 200 μg/ml; Rap: 100 nmol/l; 3-MA: 5 mmol/l.	24 h	Cell viability; Autophagosome; Autophagy.
[128]	EA.hy926	Coal-fired PM_2.5 (Yinchuan, Datong, Jingxi, Zhijin, China)	PM_2.5: 10, 25, 50 μg/ml;	24 h	Cell viability; DNA methylation; DNA damage.

Open in a new tab

Note: AP-1 activation protein-1, Bafi A1 Bafilomycin A1, DEP Diesel exhaust particles, DFOM Deferoamine mesylate, EA.hy926 human umbilical vein cell line, ER endoplasmic reticulum, ERK extracellular signal-regulated kinase, Fer-1 Ferrostatin-1, GSH glutamate, HCAECs human coronary artery endothelial cells, HMEC-1 human microvascular endothelial cells, IL interleukin, LDH lactate dehydrogenase, MAECs Mouse aorta endothelial cells, 3-MA 3-Methyadenine, MAPK mitogen-activated protein kinase, MMP Mitochondrial membrane potential, NAC N-acetyl-L-cysteine, NF-κB nuclear factor kappa-B, NIST National Institute of Standards and Technology, NO nitric oxide, 8-OHdG 8-hydroxy-2’-deoxyguanosine, PAH polycyclic aromatic hydrocarbon, 4-PBA 4-phenylbutyrate, PMA Phorbol-myristate-acetate, Rapa/Rap Rapamycin, ROS reactive oxygen species, SA-β-gal Senescence-associated (beta)-galactosidase, TNF-α tumor necrosis factor α, VE-cadherin vascular endothelial cadherin, VEGFR2 vascular endothelial growth factor receptor 2, VOC volatile organic compounds, ZO-1 Zonular Occludin-1

Ambient PM_2.5 increases vascular endothelial permeability

The proposed mechanism of PM_2.5-triggered vascular endothelial permeability increase is presented in Fig. 2a. In Balb/c mice exposed to low-dose (1.27 mg/kg) and high-dose (6.34 mg/kg) PM_2.5 through the tail vein for 48 h, PM_2.5 destroyed the integrity of vessels, as assessed by the Evans blue infiltration assay, and the results confirmed that PM_2.5 increased vascular permeability in vivo [114]. DEPs increase vascular endothelial permeability by downregulating the expression of zonula occludens-1 (ZO-1, a tight junction protein) [123]. Ambient PM_2.5 exposure disrupts the balance between antioxidation and oxidation in vascular endothelial cells, leading to increased permeability of the endothelial monolayer. Epidemiological evidence has shown that exposure to PM_2.5 reduces the anti-inflammatory and antioxidant capacity of high-density lipoprotein (HDL), and decreases the expression of antioxidant markers such as glutathione peroxidase (GSH) and superoxide dismutase (SOD) [67, 129]. A review showed that particulate matter impairs HDL function via oxidative pathways [53]. Importantly, evidence has shown that exercise training enhances HDL functions, including cholesterol efflux capacity and antioxidant capacity, and protects against endothelial dysfunction induced by PM_2.5 [130]. PM_2.5 decreases the mitochondrial membrane potential, increases reactive oxygen species (ROS) generation, and causes oxidative stress, inflammation and apoptosis in EA.hy926 cells and human umbilical vein endothelial cells (HUVECs) [110, 115, 124]. ROS play important roles in inflammatory responses, apoptosis, and cell growth, as well as in the oxidation of LDL cholesterol [131]. PM_2.5 induces ROS generation and endothelial cell apoptosis through the mitochondrial pathway in EA.hy926 cells [132]. PM_2.5 induces cell autophagy and apoptosis via endoplasmic reticulum (ER) stress in EA.hy926 cells and HUVECs [111]. Although normal autophagy seems to protect cells from PM_2.5-triggered apoptosis, PM_2.5 blocks autophagic flux and then robustly aggravates endothelial cell apoptosis [111, 122, 127]. Effective inhibition of ER stress using 4-PBA (an ER stress inhibitor) contributes to the alleviation of PM_2.5 induced cell apoptosis and the expression of LC3II [111]. Bafi A1 (an autolysosome inhibitor) aggravates PM_2.5-induced cell apoptosis by disrupting autophagic flux [111]. Exposure to PM_2.5 induces activation of the inflammatory cyclooxygenase-2 (COX-2)/prostaglandin E synthase (PGES)/prostaglandin E 2 (PGE2) axis and promotes the inflammatory response and apoptosis in mouse aorta endothelial cells (MAECs) [121]. Excessive apoptosis triggers an increase in transcellular permeability in the vascular endothelial monolayer [133]. Ambient PM_2.5 disrupts iron uptake and storage by regulating the expression of transferrin receptor (TFRC), ferritin light chain (FTL) and heavy chain (FTH1), causing intracellular iron overload and subsequently provoking ferroptosis in EA.hy926 cells and HUVECs [112]. PM_2.5 induces ROS production and lipid peroxidation in endothelial cells and increases membrane permeability [112, 134]. Furthermore, PM_2.5 induces senescence associated-β galactosidase (SA-β-gal) activation via redox sensitivity of the local angiotensin system in premature coronary arterial endothelial cells (PCAECs), leading to endothelial senescence [113]. The presence of senescent endothelial cells in a nonsenescent monolayer disrupts the tight junction morphology of surrounding young cells and increases the permeability of the monolayer [135].

Vascular endothelial (VE)-cadherin is largely expressed on endothelial cell membranes. The extracellular domain of VE-cadherin mediates endothelial cell-to-cell adhesion through hemophilic trans interactions, whereas its cytoplasmic tail associates with the actin cytoskeleton, strengthening the adhesion junction between endothelial cells [136]. Thus, VE-cadherin plays a key role in maintaining endothelial barrier integrity, controlling the transmembrane movement of macromolecule substances such as blood cells. PM_2.5 induces the phosphorylation of vascular endothelial growth factor receptor 2 (VEGFR2) on the endothelial cell membrane and activates downstream mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) signaling, leading to the shedding of adhesion connexin VE-cadherin [114]. PM_2.5 induces endothelial cell cytoskeleton rearrangement via Rho-dependent pathways to facilitate vascular hyperpermeability [137]. Targeting of tissue inhibitor of metalloproteinase 3 (TIMP3)/MMP9 and VE-cadherin by miR-21 in response to PM_2.5 increases vascular endothelial cell permeability in HUVECs [108]. Inflammation stimulates a series of signaling pathways that reduce the level of VE-cadherin expressed or induces VE-cadherin phosphorylation and then destroys the adhesion structure [138].

Ambient PM_2.5 impairs vasomotor function

Endothelin-1 (ET-1) is a protein primarily produced by endothelial cells that regulates cell proliferation and vascular tone by activating its receptors, including type A (ET_A) and type B (ET_B) [139]. Evidence has indicated that inflammation, ischemia and hypoxia stimulate the expression of ET-1 and its receptors [140]. Qinghua Sun et al. exposed ApoE^-/- mice to concentrated ambient PM_2.5 for 6 months and assessed the vasoconstriction of aortic rings in response to phenylephrine and serotonin and vasorelaxation in response to acetylcholine. The results demonstrated that PM_2.5 significantly increased the constriction of the aorta, especially in high-fat diet-fed mice [101]. The proposed mechanism of by which PM_2.5 causes endothelial vasomotor function impairment is presented in Fig. 2b. PM_2.5 elevates the circulating levels of AngII, locally activates the AngII/AngII type 1 receptor (AT1R) axis and activates phospholipase C (PLC) and protein kinase C (PKC), promoting ET-1 biosynthesis in HUVECs [116]. ET-1 is released from endothelial cells, acts on the endothelial ET_B receptor and increases nitric oxide (NO) production [141]. The production of NO by endothelial cells contributes to regulating vasomotor tone. NO cats on circulating blood platelets, leukocytes and adjacent smooth muscle cells and reduces smooth muscle cell contractility [142]. PM_2.5 impairs the balance of vasorelaxation by oxidative stress, and superoxide radicals combine with NO to form peroxynitrite, thus reducing NO bioavailability in the vessel wall [143]. Furthermore, PM_2.5 upregulates the expression of ET_B and ET_A receptors in rat coronary arteries [144]. ET_B in vascular endothelial cells mediates the vasodilation, while ET_A and ET_B in vascular smooth muscle cells mediate the contractility, especially ET_A activation, which plays a greater role in coronary vasoconstriction [141]. ET-1 in the vasculature causes brief vessel relaxation due to ET_B activation in endothelial cells. However, this effect is quickly reversed by ET-1 binding to ET_A, which reduces NO production in vascular smooth muscle cells and leads to the well-known constrictive effects of ET-1 in the vasculature [145]. Therefore, PM_2.5 upregulates the expression of ET_B and ET_A receptors in coronary arteries, but PM_2.5 mainly increases vasoconstriction and contributes to the progression of atherosclerosis. AngII enhances ET-1-mediated vasoconstriction by upregulating the expression of ET_A in VSMCs [146]. In addition, PM_2.5 exposure causes vascular insulin resistance and suppresses insulin-stimulated endothelial nitric oxide synthase (eNOS) phosphorylation (likely an endothelial-specific event) [147]. Insulin stimulates the phosphorylation of eNOS and increases eNOS activity and NO production [148–150]. Therefore, PM_2.5-provoked endothelial insulin resistance could be a key event in regulating vascular tone. In brief, PM_2.5 shifts the balance of vasomotor tone towards vasoconstriction by increasing the levels of ET-1 and its receptors, as well as decreasing NO production and bioavailability. Exercise training effectively prevents the imbalance in vasomotor function triggered by PM_2.5 [130].

Ambient PM_2.5 suppresses vascular endothelial repair

Endothelial progenitor cells (EPCs), a group of stem cells/progenitor cells, settle in the adult bone marrow and can mobilize to the peripheral blood, home to sites of vascular injury, proliferate and differentiate into endothelial cells, and facilitate vascular recovery [151]. In addition to exerting antioxidative and anti-inflammatory effects, HDL protects EPCs by increasing eNOS levels and decreasing MMP9 levels, thereby reducing the apoptosis of EPCs [152]. Bone marrow-derived EPCs from C57BL/6 mice exposed to PM_2.5 inhalation for 9 or 30 days were injected into unexposed mice subjected to hind limb ischemia and vascular perfusion was assessed by laser Doppler perfusion imaging (LDPI). The results confirmed that PM_2.5 significantly impaired angiogenesis and that bone marrow-derived EPCs have vascular reparative capacity in vivo [153]. The proposed mechanism of PM_2.5-triggered vascular repair suppression is presented in Fig. 2c. In C57BL/6 mice exposed to concentrated PM_2.5 inhalation for 9 or 30 consecutive days (6 h/day), PM_2.5 impaired endothelial progenitor cellular differentiation and mobilization through vascular insulin resistance and nuclear factor kappa-B (NF-κB) and inflammasome activation, while insulin sensitizers prevented PM_2.5-triggered vascular insulin resistance and inflammation and decreased circulating EPCs [154]. ROS and inflammation suppress the proliferation of EPCs and enhance the apoptosis of EPCs [155]. Furthermore, PM_2.5 decreases the abundance of EPCs, and impairs EPC functions and prevents EPC-mediated vascular endothelial recovery associated with vascular endothelial growth factor (VEGF) resistance and a decrease in NO bioavailability [153]. In addition to EPCs, the proliferation and migration abilities of mature endothelial cells are additional important factors in endothelial injury repair. Endothelial cell proliferation and migration are initially required for arterial repair after injury [156]. PM_2.5 decreases the viability and suppresses the proliferation and migration of HUVECs and human microvascular endothelial cells through oxidative stress [117]. In brief, PM_2.5 disrupts two major factors involved in repairing vascular endothelial damage: a. the abundance and function of EPCs and b. the proliferation and migration abilities of endothelial cells.

Ambient PM_2.5-triggered endothelial injury and atherosclerosis

Ambient PM_2.5 causes a pro-coagulant state

Atherosclerosis is characterized by the accumulation of inflammatory cells and lipids in the walls of arteries. The intact endothelial cell layer exerts the first defense to hinder the development of atherosclerosis. Endothelial cell-derived mediators take part in hemostasis, including tissue factor (TF), tissue factor pathway inhibitors (TFPI), thrombomodulin (TM), and von Willebrand factor (vWF) [157, 158]. For example, normal vascular endothelium-synthesized TFPI regulates the balance between coagulation and fibrinolysis [44]. Exposure to air pollution affects each of these dynamic processes, and increasing evidence suggests that the balance of between platelet activation, coagulation and fibrinolysis shifts towards a pro-coagulant and anti-fibrinolytic state [8]. Sprague-Dawley (SD) rats were exposed to PM_2.5 (1.8, 5.4, 16.2 mg/kg bw) by intratracheal instillation every three days for 30 days, and the results showed that PM_2.5 increased the expression of TF in the vessel wall and activated coagulation factors VII and X and the formation of thrombin [158–160]. PM_2.5 reduces the expression of TM in the vascular endothelial monolayer, thereby decreasing anti-coagulant function [160]. vWF is mainly released by activated endothelial cells, which bridge platelets and aggregates in the injured vessel walls [161]. PM_2.5 downregulates the expression of vWF in the serum and promotes the adherence of platelets to injured endothelial layers, implying that vWF is consumed during the process of platelet aggregation after exposure to PM_2.5 [104, 160]. Platelet adhesion, aggregation and coagulation are implicated in inflammatory pathologies of atherosclerosis [162, 163].

Ambient PM_2.5 induces an inflammatory response

Short-term exposure to PM_2.5 induces systemic inflammation and increases the circulation levels of inflammatory biomarkers such as CRP, tumor necrosis factor α (TNF-α), IL-6, IL-8 and MCP-1 [35, 164]. PM_2.5 triggers the secretion of IL-6 and IL-1β by activating the TLR-mediated pathway in HUVECs, while TLR2 and TLR4 inhibitors reduce the PM_2.5-triggered inflammatory response [120]. PM_2.5 triggers endothelial activation, increases the expression of adhesion molecules (ICAM-1 and VCAM-1) and induces THP-1 cell adhesion to endothelial cells through the ERK/AKT/NF-κB-dependent pathway in EA.hy926 cells; moreover, ERK/AKT/NF-κB inhibitors have been used to demonstrate the abovementioned effects [118]. Monocytes in the blood adhere to endothelial cells through adhesion molecules and then migrate into the vascular wall [126, 165]. Monocytes that enter the blood vessel wall transform into macrophages, which clear lipids and dead or dying cells [166]. Exposure of ApoE^-/- or LDLR^-/- mice to concentrated ambient PM_2.5 for 6 months (6 h/day, 5 days/week) showed that PM_2.5 significantly increases the expression of CD36 in plaque macrophages, increases the internalization of ox-LDL and mediates macrophage-derived foam cell formation [12]. Both macrophage-derived foam cells and necrotic cells release various inflammatory factors (such as TNF, IL-1, and IL-6), thereby expanding the inflammatory response cascade and inducing persistent inflammation in local blood vessels [166]. Moreover, evidence from animal experiments has shown that inflammation is significantly unregulated in ApoE^-/- mice after exposure to PM_2.5 (10 mg/kg bw) for two months and that inflammation increases even if PM_2.5 exposure is stopped [6]. The above evidence focuses on the effects of PM_2.5 on inflammation and atherosclerosis.

Ambient PM_2.5 promotes lipid deposition

Lipid deposition is one of the key factors promoting the development of atherosclerosis, especially ox-LDL deposition, which contributes to necrotic core formation. In the past few decades, lowering lipid levels has been the main strategy for the treatment of atherosclerosis [167]. However, currently, two views about how lipids enter and deposit in the vascular wall are held. It has been believed that damaged vascular walls cause LDL infiltration into the vascular wall and induce the development of atherosclerosis [168]. Professor Shaul holds a different view, suggesting that the receptor scavenger receptor type B1 (SR-B1) on endothelial cells has a transcytosis effect on LDL and promotes the accumulation of LDL in the vascular wall [169]. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is expressed in endothelial cells, monocytes/macrophages and vascular smooth muscle cells and is essential for binding to oxLDL [170]. Pro-inflammatory and pro-oxidant, and mechanical stimuli including ox-LDL, TNF-α, Ang II and shear stress, can rapidly activate the expression of LOX-1 [171]. In endothelial cells, LOX-1 activation induces inflammation, reduces eNOS activation and NO availability, and triggers endothelial dysfunction [172]. Ox-LDL induces the release of the soluble form of LOX-1 (sLOX-1) from endothelial cells into the circulation and the level of sLOX-1 correlates with carotid plaque inflammation and risk for ischemic stroke [173]. Inhaled vehicle emissions trigger significant increases in plasma sLOX-1 levels in humans and mediate the upregulation of ET-1 and MMP9 expression via ox-LDL-LOX-1 receptor signaling, further inducing vascular effects [174]. LOX-1 protein levels are increased in the aorta after coexposure to ozone and DEPs [175]. Moreover, in ApoE^-/- mice exposed to a mixture of gasoline and diesel engine exhaust (MVE), the expression of LOX-1 was increased in cerebral microvascular endothelial cells, and at least in part, MVE altered the structure and integrity of the brain microvasculature via LOX-1 signaling [176]. Many studies have demonstrated that PM_2.5 contributes to lipid dysregulation in the sera of ApoE^-/- mice and promotes macrophage engulfment of ox-LDL through surface scavenger receptors to induce foam cell formation [6, 12, 177]. However, studies on the effect of PM_2.5 on lipid uptake and transport in endothelial cells are lacking, although limited evidence has shown that traffic-derived pollutants increase LOX-1 signaling in endothelial cells. In addition to inflammation, lipid uptake and transport are key factors in the development of atherosclerosis. Thus, the effect of PM_2.5 on the binding of ox-LDL to endothelial cells is an area of intense investigation.

Indoor PM_2.5 elicits endothelial dysfunction and atherosclerosis

WHO data has shown that more than 41% of households are still using solid fuels and kerosene for cooking, producing harmful smoke in the home and causing the death of approximately 916 thousand individuals from cardiovascular disease [178]. CIMT is a marker of subclinical atherosclerosis. Recently, epidemiological evidence showed that PM_2.5 emissions from biomass cooking fuel in peri-urban villages of India were positively associated with increased CIMT [61]. Consistent with this study, Matthew S Painschab et al. also showed that indoor PM_2.5 sourced from biomass fuel in Puno, Peru, was associated with CIMT, an enhanced prevalence of atherosclerotic plaque and increased blood pressure [88]. In the rural villages of Sichuan, China, household PM_2.5 from biomass stoves is associated with central hemodynamics and increased blood pressure; however, it is not associated with pulse wave velocity (PWV, a marker of arterial stiffness) [87]. Indoor particles impair microvascular function through inflammation and oxidative stress [179]. Cooking oil fumes (COFs), the main pollutants in kitchen air, can significantly reduce cellular viability, and inhibit angiogenesis in HUVECs through the ROS-mediated NLRP3 inflammasome pathway or VEGF/VEGFR2/MEK1/2/ERK1/2/mTOR pathway [40, 119]. COF-derived PM_2.5 mediates autophagy via the ROS/AKT/mTOR axis in HUVECs [180]. Evidence for the mediating role of indoor PM_2.5 in vascular endothelial dysfunction is limited.

Conclusion

In summary, PM_2.5 exposure is positively associated with atherosclerosis based on epidemiological evidence. Epidemiological and animal experimental evidence has established that PM_2.5-induced atherosclerosis is mainly mediated by inflammation and lipid metabolism alterations. On the basis of in vivo and in vitro studies, PM_2.5 induces vascular endothelial dysfunction and a procoagulant state and increases inflammation and lipid abnormalities, thus promoting the development of atherosclerosis. However, only a few studies have tried to explore preventive measures. It would be meaningful to explore measures or targets that can contribute to the prevention of PM_2.5-induced endothelial dysfunction or atherosclerosis, which remains to be solved before the environment improves. Changes occur at the molecular level significantly earlier than histopathology and clinical symptoms. Consequently, improving the understanding of molecular mechanisms will be helpful in preventing the occurrence or development of atherosclerosis, or identifying potential therapeutic targets for atherosclerosis treatment.

Acknowledgments

Not applicable.

Abbreviations

AAC: Abdominal aortic calcium agatston score
ABCA1: ATP-binding cassette transporter A1
AngII: Angiotensin II
aHR: Adjusted hazard ratio
AT1R: AngII type 1 receptor
AIx: Augmentation index
ApoA1: Apolipoprotein A1
ApoB: Apolipoprotein B
AP-1: Activation protein-1
ASC: Apoptosis associated speck like protein
Bafi A1: Bafilomycin A1
BC: Black carbon
BP: Blood pressure
baPWV: Brachial-ankle pulse wave velocity
CAC: Coronary artery calcification
CCS: Coronary artery calcium score
CD36: Cluster of differentiation 36
cfPWV: Carotid-femoral PWV
CI: Confidence interval
CIMT: Carotid intima-media thickness
COFs: Cooking oil fumes
COX-2: Cyclooxygenase -2
CRP: C-reactive protein
DEG: Diesel exhaust gases
DFOM: Deferoamine mesylate
EA.hy926: Human umbilical vein cell line
EC: Elemental carbon
eNOS: Endothelial nitric oxide synthase
EPC: Endothelial progenitor cells
ET-1: Endothelin-1
ET_A: Endothelin type A
ET_B: Endothelin type B
ER: Endoplasmic reticulum
ERK: Extracellular signal-regulated kinase
FA: Filtered air
Fer-1: Ferrostatin-1
Foxp3: Forkhead box transcription factor P3
FTL: Ferritin light chain
FTH1: Ferritin heavy chain
GSH: Glutathione peroxidase
GSH-Px: Glutathione peroxidase
HDL: High-density lipoprotein
HDL-C: High density lipoprotein-cholesterol
HDL-P: High-density lipoprotein cholesterol particle matter
HOI: HDL oxidant index
Hs-CRP: High sensitive C-reactive protein
HRP: High-risk plaque
HUVECs: Human umbilical vein endothelial cells
IL: Interleukin
IAD: Inter-adventitial diameter
IMT: Intima-media thickness
iNOS: Inducible nitric oxide synthase
IQR: Interquartile
7-KCh: 7-ketocholesterol
LDH: Lactate dehydrogenase
LDL: Low-density lipoprotein
LDL-C: Low density lipoprotein-cholesterol
LDPI: Laser Doppler perfusion imaging
LOX-1: Lectin-like oxidized low-density lipoprotein receptor-1
LXR-α: Liver X receptor α
MAECs: Mouse aorta endothelial cells
3-MA: 3-Methyadenine
MAPK: Mitogen-activated protein kinase
MCP: Monocyte chemoattractant protein
MDA: Malondialdehyde
MMP: Matrix metalloproteinase
MMP: Mitochondrial membrane potential
MRI: Magnetic resonance imaging
NAC: N-acetyl-L-cysteine
NF-κB: Nuclear factor kappa-B
NO: Nitric oxide
NIST: National Institute of Standards and Technology
8-OHdG: 8-hydroxy-2’-deoxyguanosine
NLRP3: NOD-like receptor protein 3
O₃: Ozone
OC: Organic carbon
OR: Odds ratio
ox-LDL: Oxidized low-density lipoprotein
PAH: Polycyclic aromatic hydrocarbon
4-PBA: 4-phenylbutyrate
PCAECs: Premature coronary arterial endothelial cells
PGES: Prostaglandin E synthase
PGE2: Prostaglandin E 2
PM_2.5: Fine particulate matter
PM_2.5abs: Absorbance levels of PM_2.5
PMA: Phorbol-myristate-acetate
PLC: Phospholipase C
PKC: Protein kinase C
PNacc: Particle number of accumulation mode particles
PP: Pilse pressure
PWV: Pulse wave velocity
Rapa/Rap: Rapamycin
ROS: Reactive oxygen species
SA-β-gal: Senescence associated-β galactosidase
SBP: Systolic blood pressure
SO₂: Sulfur dioxide
SOD: Superoxide dismutase
sICAM-1: Soluble Intercellular Adhesion Molecule-1
SR-BI: Scavenger receptor type B1
TAC: Thoracic aortic calcium agatston score
T-AOC: Total antioxidant capacity
TC: Total cholesterol
TF: Tissue factor
TFPI: Tissue factor pathway inhibitors
TFRC: Transferrin receptor
TG: Triglycerides
TGF-β: Ttransforming growth factor-β
TM: Thrombomodulin
TIMP3: Tissue inhibitor of metalloproteinase 3
TNF-α: Tumor necrosis factor α
TLR: Toll-like receptor
UFP: Ultrafine particles
VCAM-1: Vascular cell adhesion molecule-1
VE: Vascular endothelial
VEGF: Vascular endothelial growth factor
VEGFR2: Vascular endothelial growth factor receptor 2
VOC: Volatile organic compounds
VSMCs: Vascular smooth muscle cells
vWF: Von willebrand factor
WDE: Whole diesel exhaust
WHO: World Health Organization
ZO-1: zonula occludens-1

Authors’ contributions

All authors contributed to the design, concept and grammar in this article. Junchao Duan and Zhiwei Sun revised the manuscript. All authors read and approved the final manuscript.

Funding

This work was supported by National Key Research and Development Program of China (2017YFC0211600, 2017YFC0211602, 2017YFC0211606), National Natural Science Foundation of China (91943301), Beijing Nova Program (Z181100006218027) and Beijing Outstanding Talent Training Program, Beijing Natural Science Foundation Program and Scientific Research Key Program of Beijing Municipal Commission of Education (KZ202110025040).

Availability of data and materials

Databases/repositories and materials is not applicable in this review.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declared they had no conflict of interest.

Footnotes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Shuang Liang, Email: sliang0205@163.com.

Jingyi Zhang, Email: zjyyufangyx@163.com.

Ruihong Ning, Email: 13643512270@139.com.

Zhou Du, Email: superdzzzzzz@163.com.

Jiangyan Liu, Email: journey1479@163.com.

Joe Werelagi Batibawa, Email: werelagi@gmail.com.

Junchao Duan, Email: jcduan@ccmu.edu.cn.

Zhiwei Sun, Email: zwsun@hotmail.com.

References

1.Mannucci PM, Harari S, Franchini M. Novel evidence for a greater burden of ambient air pollution on cardiovascular disease. Haematologica. 2019;104(12):2349–2357. doi: 10.3324/haematol.2019.225086. [DOI] [PMC free article] [PubMed] [Google Scholar]
2.Benziger CP, Roth GA, Moran AE. The Global Burden of Disease Study and the Preventable Burden of NCD. Glob Heart. 2016;11(4):393–397. doi: 10.1016/j.gheart.2016.10.024. [DOI] [PubMed] [Google Scholar]
3.Cohen AJ, Brauer M, Burnett R, Anderson HR, Frostad J, Estep K, et al. Estimates and 25-year trends of the global burden of disease attributable to ambient air pollution: an analysis of data from the Global Burden of Diseases Study 2015. Lancet. 2017;389(10082):1907–1918. doi: 10.1016/s0140-6736(17)30505-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
4.Liang CS, Duan FK, He KB, Ma YL. Review on recent progress in observations, source identifications and countermeasures of PM2.5. Environ Int. 2016;86:150–170. doi: 10.1016/j.envint.2015.10.016. [DOI] [PubMed] [Google Scholar]
5.Walter CM, Schneider-Futschik EK, Knibbs LD, Irving LB. Health impacts of bushfire smoke exposure in Australia. Respirology. 2020. 10.1111/resp.13798. [DOI] [PubMed]
6.Zhang J, Liang S, Ning R, Jiang J, Zhang J, Shen H, et al. PM2.5-induced inflammation and lipidome alteration associated with the development of atherosclerosis based on a targeted lipidomic analysis. Environ Int. 2020;136:105444. doi: 10.1016/j.envint.2019.105444. [DOI] [PubMed] [Google Scholar]
7.Park SK, Auchincloss AH, O'Neill MS, Prineas R, Correa JC, Keeler J, et al. Particulate air pollution, metabolic syndrome, and heart rate variability: the multi-ethnic study of atherosclerosis (MESA) Environ Health Perspect. 2010;118(10):1406–1411. doi: 10.1289/ehp.0901778. [DOI] [PMC free article] [PubMed] [Google Scholar]
8.Brook RD, Rajagopalan S, Pope CA, 3rd, Brook JR, Bhatnagar A, Diez-Roux AV, et al. Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation. 2010;121(21):2331–2378. doi: 10.1161/CIR.0b013e3181dbece1. [DOI] [PubMed] [Google Scholar]
9.Jiang Y, Lu H, Man Q, Liu Z, Wang L, Wang Y, et al. Stroke burden and mortality attributable to ambient fine particulate matter pollution in 195 countries and territories and trend analysis from 1990 to 2017. Environ Res. 2020;184:109327. doi: 10.1016/j.envres.2020.109327. [DOI] [PubMed] [Google Scholar]
10.Zhu YH, Xian XM, Wang ZZ, Bi YC, Chen QG, Han XF, et al. Research Progress on the Relationship between Atherosclerosis and Inflammation. Biomolecules. 2018;8:3. doi: 10.3390/biom8010003. [DOI] [PMC free article] [PubMed] [Google Scholar]
11.Bäck M, Yurdagul A, Jr, Tabas I, Öörni K, Kovanen PT. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities. Nat Rev Cardiol. 2019;16(7):389–406. doi: 10.1038/s41569-019-0169-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
12.Rao X, Zhong J, Maiseyeu A, Gopalakrishnan B, Villamena FA, Chen LC, et al. CD36-dependent 7-ketocholesterol accumulation in macrophages mediates progression of atherosclerosis in response to chronic air pollution exposure. Circ Res. 2014;115(9):770–780. doi: 10.1161/circresaha.115.304666. [DOI] [PMC free article] [PubMed] [Google Scholar]
13.Mueller PA, Zhu L, Tavori H, Huynh K, Giunzioni I, Stafford JM, et al. Deletion of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Accelerates Atherosclerosis Regression and Increases C-C Chemokine Receptor Type 7 (CCR7) Expression in Plaque Macrophages. Circulation. 2018;138(17):1850–1863. doi: 10.1161/circulationaha.117.031702. [DOI] [PMC free article] [PubMed] [Google Scholar]
14.Tang SL, Chen WJ, Yin K, Zhao GJ, Mo ZC, Lv YC, et al. PAPP-A negatively regulates ABCA1, ABCG1 and SR-B1 expression by inhibiting LXRα through the IGF-I-mediated signaling pathway. Atherosclerosis. 2012;222 2:344-354; doi: 10.1016/j.atherosclerosis.2012.03.005. [DOI] [PubMed]
15.Zeng Y, Peng Y, Tang K, Wang YQ, Zhao ZY, Wei XY, et al. Dihydromyricetin ameliorates foam cell formation via LXRα-ABCA1/ABCG1-dependent cholesterol efflux in macrophages. Biomed Pharmacother. 2018;101:543–552. doi: 10.1016/j.biopha.2018.02.124. [DOI] [PubMed] [Google Scholar]
16.Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011;473(7347):317–325. doi: 10.1038/nature10146. [DOI] [PubMed] [Google Scholar]
17.Gough PJ, Gomez IG, Wille PT, Raines EW. Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. J Clin Invest. 2006;116(1):59–69. doi: 10.1172/jci25074. [DOI] [PMC free article] [PubMed] [Google Scholar]
18.Saba L, Saam T, Jager HR, Yuan C, Hatsukami TS, Saloner D, et al. Imaging biomarkers of vulnerable carotid plaques for stroke risk prediction and their potential clinical implications. Lancet Neurol. 2019;18(6):559–572. doi: 10.1016/S1474-4422(19)30035-3. [DOI] [PubMed] [Google Scholar]
19.Sharkey J, Starkey Lewis PJ, Barrow M, Alwahsh SM, Noble J, Livingstone E, et al. Functionalized superparamagnetic iron oxide nanoparticles provide highly efficient iron-labeling in macrophages for magnetic resonance-based detection in vivo. Cytotherapy. 2017;19(4):555–569. doi: 10.1016/j.jcyt.2017.01.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
20.Robson PM, Dweck MR, Trivieri MG, Abgral R, Karakatsanis NA, Contreras J, et al. Coronary Artery PET/MR Imaging: Feasibility, Limitations, and Solutions. JACC Cardiovasc Imaging. 2017;10(10 Pt A):1103–1112. doi: 10.1016/j.jcmg.2016.09.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
21.Hop H, de Boer SA, Reijrink M, Kamphuisen PW, de Borst MH, Pol RA, et al. (18)F-sodium fluoride positron emission tomography assessed microcalcifications in culprit and non-culprit human carotid plaques. J Nucl Cardiol. 2019;26(4):1064–1075. doi: 10.1007/s12350-018-1325-5.. [DOI] [PMC free article] [PubMed] [Google Scholar]
22.Sundboll J, Larsen AP, Veres K, Adelborg K, Sorensen HT. Cardiovascular event rates and trajectories of LDL-cholesterol levels and lipid-lowering therapy in patients with atherosclerotic cardiovascular disease: A population-based cohort study. Thromb Res. 2019;183:124–130. doi: 10.1016/j.thromres.2019.09.034. [DOI] [PubMed] [Google Scholar]
23.Wang J, Geng NB, Xu YF, Zhang WD, Tang XY, Zhang RQ. PAHs in PM2.5 in Zhengzhou: concentration, carcinogenic risk analysis, and source apportionment. Environ Monit Assess. 2014;186(11):7461–7473. doi: 10.1007/s10661-014-3940-1. [DOI] [PubMed] [Google Scholar]
24.Hellén H, Hakola H, Haaparanta S, Pietarila H, Kauhaniemi M. Influence of residential wood combustion on local air quality. Sci Total Environ 2008;393 2-3:283-90; doi: 10.1016/j.scitotenv.2008.01.019. [DOI] [PubMed]
25.Miller MR, McLean SG, Duffin R, Lawal AO, Araujo JA, Shaw CA, et al. Diesel exhaust particulate increases the size and complexity of lesions in atherosclerotic mice. Part Fibre Toxicol. 2013;10:61. doi: 10.1186/1743-8977-10-61. [DOI] [PMC free article] [PubMed] [Google Scholar]
26.Pöss J, Lorenz D, Werner C, Pavlikova V, Gensch C, Speer T, et al. Diesel exhaust particles impair endothelial progenitor cells, compromise endothelial integrity, reduce neoangiogenesis, and increase atherogenesis in mice. Cardiovasc Toxicol. 2013;13(3):290–300. doi: 10.1007/s12012-013-9208-0. [DOI] [PubMed] [Google Scholar]
27.Brinchmann BC, Le Ferrec E, Podechard N, Lagadic-Gossmann D, Holme JA, Øvrevik J. Organic chemicals from diesel exhaust particles affects intracellular calcium, inflammation and β-adrenoceptors in endothelial cells. Toxicol Lett. 2019;302:18–27. doi: 10.1016/j.toxlet.2018.11.009. [DOI] [PubMed] [Google Scholar]
28.Holme JA, Brinchmann BC, Le Ferrec E, Lagadic-Gossmann D, Øvrevik J. Combustion Particle-Induced Changes in Calcium Homeostasis: A Contributing Factor to Vascular Disease? Cardiovasc Toxicol. 2019;19(3):198–209. doi: 10.1007/s12012-019-09518-9. [DOI] [PubMed] [Google Scholar]
29.Brinchmann BC, Skuland T, Rambøl MH, Szoke K, Brinchmann JE, Gutleb AC, et al. Lipophilic components of diesel exhaust particles induce pro-inflammatory responses in human endothelial cells through AhR dependent pathway(s) Part Fibre Toxicol. 2018;15(1):21. doi: 10.1186/s12989-018-0257-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
30.Brinchmann BC, Le Ferrec E, Podechard N, Lagadic-Gossmann D, Shoji KF, Penna A. Lipophilic Chemicals from Diesel Exhaust Particles Trigger Calcium Response in Human Endothelial Cells via Aryl Hydrocarbon Receptor Non-Genomic Signalling. Intern J Mol Sci. 2018;19:5. 10.3390/ijms19051429. [DOI] [PMC free article] [PubMed]
31.Alshaarawy O, Elbaz HA, Andrew ME. The association of urinary polycyclic aromatic hydrocarbon biomarkers and cardiovascular disease in the US population. Environ Int. 2016;89-90:174-178; doi: 10.1016/j.envint.2016.02.006. [DOI] [PMC free article] [PubMed]
32.Manisalidis I, Stavropoulou E, Stavropoulos A, Bezirtzoglou E. Environmental and Health Impacts of Air Pollution: A Review. Front Public Health. 2020;8:14. doi: 10.3389/fpubh.2020.00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
33.Munzel T, Gori T, Al-Kindi S, Deanfield J, Lelieveld J, Daiber A, et al. Effects of gaseous and solid constituents of air pollution on endothelial function. Eur Heart J. 2018;39(38):3543–3550. doi: 10.1093/eurheartj/ehy481. [DOI] [PMC free article] [PubMed] [Google Scholar]
34.Rao X, Zhong J, Brook RD, Rajagopalan S. Effect of Particulate Matter Air Pollution on Cardiovascular Oxidative Stress Pathways. Antioxid Redox Signal. 2018;28(9):797–818. doi: 10.1089/ars.2017.7394. [DOI] [PMC free article] [PubMed] [Google Scholar]
35.Zhang Q, Niu Y, Xia Y, Lei X, Wang W, Huo J, et al. The acute effects of fine particulate matter constituents on circulating inflammatory biomarkers in healthy adults. Sci Total Environ. 2020;707:135989. doi: 10.1016/j.scitotenv.2019.135989. [DOI] [PubMed] [Google Scholar]
36.Bekki K, Ito T, Yoshida Y, He C, Arashidani K, He M, et al. PM2.5 collected in China causes inflammatory and oxidative stress responses in macrophages through the multiple pathways. Environ Toxicol Pharmacol. 2016;45:362–369. doi: 10.1016/j.etap.2016.06.022. [DOI] [PubMed] [Google Scholar]
37.Pope CA, 3rd, Bhatnagar A, McCracken JP, Abplanalp W, Conklin DJ, O'Toole T. Exposure to Fine Particulate Air Pollution Is Associated With Endothelial Injury and Systemic Inflammation. Circ Res. 2016;119(11):1204–1214. doi: 10.1161/circresaha.116.309279. [DOI] [PMC free article] [PubMed] [Google Scholar]
38.Hajat A, Allison M, Diez-Roux AV, Jenny NS, Jorgensen NW, Szpiro AA, et al. Long-term exposure to air pollution and markers of inflammation, coagulation, and endothelial activation: a repeat-measures analysis in the Multi-Ethnic Study of Atherosclerosis (MESA) Epidemiology. 2015;26(3):310–320. doi: 10.1097/ede.0000000000000267. [DOI] [PMC free article] [PubMed] [Google Scholar]
39.Wu CF, Shen FH, Li YR, Tsao TM, Tsai MJ, Chen CC, et al. Association of short-term exposure to fine particulate matter and nitrogen dioxide with acute cardiovascular effects. Sci Total Environ. 2016;569-570:300–305. doi: 10.1016/j.scitotenv.2016.06.084. [DOI] [PubMed] [Google Scholar]
40.Shen C, Liu J, Zhu F, Lei R, Cheng H, Zhang C, et al. The effects of cooking oil fumes-derived PM2.5 on blood vessel formation through ROS-mediated NLRP3 inflammasome pathway in human umbilical vein endothelial cells. Ecotoxicol Environ Saf. 2019;174:690–698. doi: 10.1016/j.ecoenv.2019.03.028. [DOI] [PubMed] [Google Scholar]
41.Soppa VJ, Shinnawi S, Hennig F, Sasse B, Hellack B, Kaminski H, et al. Effects of short-term exposure to fine and ultrafine particles from indoor sources on arterial stiffness - A randomized sham-controlled exposure study. Int J Hyg Environ Health. 2019;222(8):1115–1132. doi: 10.1016/j.ijheh.2019.08.002. [DOI] [PubMed] [Google Scholar]
42.Pate M, Damarla V, Chi DS, Negi S, Krishnaswamy G. Endothelial cell biology: role in the inflammatory response. Adv Cin Chem. 2010;52:109–130. doi: 10.1016/S0065-2423(10)52004-3. [DOI] [PubMed] [Google Scholar]
43.Brook RD, Brook JR, Urch B, Vincent R, Rajagopalan S, Silverman F. Inhalation of fine particulate air pollution and ozone causes acute arterial vasoconstriction in healthy adults. Circulation. 2002;105(13):1534–1536. doi: 10.1161/01.cir.0000013838.94747.64. [DOI] [PubMed] [Google Scholar]
44.Daiber A, Steven S, Weber A, Shuvaev VV, Muzykantov VR, Laher I, et al. Targeting vascular (endothelial) dysfunction. Br J Pharmacol. 2017;174(12):1591–1619. doi: 10.1111/bph.13517. [DOI] [PMC free article] [PubMed] [Google Scholar]
45.Lawal AO, Davids LM, Marnewick JL. Diesel exhaust particles and endothelial cells dysfunction: An update. Toxicol in Vitro. 2016;32:92–104. doi: 10.1016/j.tiv.2015.12.015. [DOI] [PubMed] [Google Scholar]
46.Fang X, Li R, Xu Q, Bottai M, Fang F, Cao Y. A Two-Stage Method to Estimate the Contribution of Road Traffic to PM(2).(5) Concentrations in Beijing, China. Int J Environ Res Public Health. 2016;13:1. doi: 10.3390/ijerph13010124. [DOI] [PMC free article] [PubMed] [Google Scholar]
47.Ito K, Xue N, Thurston GJAE. Spatial variation of PM2.5 chemical species and source-apportioned mass concentrations in New York City. Atmos Environ. 2004;38(31):5269–5282. doi: 10.1016/j.atmosenv.2004.02.063. [DOI] [Google Scholar]
48.Chuersuwan N, Nimrat S, Lekphet S, Kerdkumrai T. Levels and major sources of PM2.5 and PM10 in Bangkok Metropolitan Region. Environ Int. 2008;34(5):671–677. doi: 10.1016/j.envint.2007.12.018. [DOI] [PubMed] [Google Scholar]
49.Miller MR, Newby DE. Air pollution and cardiovascular disease: car sick. Cardiovasc Res. 2020;116(2):279–294. doi: 10.1093/cvr/cvz228. [DOI] [PubMed] [Google Scholar]
50.Choi SH, Harkewicz R, Lee JH, Boullier A, Almazan F, Li AC, et al. Lipoprotein accumulation in macrophages via toll-like receptor-4-dependent fluid phase uptake. Circ Res. 2009;104(12):1355–1363. doi: 10.1161/circresaha.108.192880. [DOI] [PMC free article] [PubMed] [Google Scholar]
51.Geng J, Liu H, Ge P, Hu T, Zhang Y, Zhang X, et al. PM2.5 promotes plaque vulnerability at different stages of atherosclerosis and the formation of foam cells via TLR4/MyD88/NFkappaB pathway. Ecotoxicol Environ Saf. 2019;176:76–84. doi: 10.1016/j.ecoenv.2019.03.068. [DOI] [PubMed] [Google Scholar]
52.Liu J, Liang S, Du Z, Zhang J, Sun B, Zhao T, et al. PM(2.5) aggravates the lipid accumulation, mitochondrial damage and apoptosis in macrophage foam cells. Environ Pollut. 2019;249:482–490. doi: 10.1016/j.envpol.2019.03.045. [DOI] [PubMed] [Google Scholar]
53.Holme SAN, Sigsgaard T. Effects of particulate matter on atherosclerosis: a link via high-density lipoprotein (HDL) functionality? Part Fibre Toxicol. 2020;17(1):36. doi: 10.1186/s12989-020-00367-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
54.Doran AC, Yurdagul A, Jr, Tabas I. Efferocytosis in health and disease. Nat Rev Immunol. 2020;20(4):254–267. doi: 10.1038/s41577-019-0240-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
55.Wan Q, Liu Z, Yang Y. Puerarin inhibits vascular smooth muscle cells proliferation induced by fine particulate matter via suppressing of the p38 MAPK signaling pathway. BMC Complement Altern Med. 2018;18(1):146. doi: 10.1186/s12906-018-2206-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
56.Cao Y, Long J, Ji Y, Chen G, Shen Y, Gong Y, et al. Foam cell formation by particulate matter (PM) exposure: a review. Inhal Toxicol. 2016;28(13):583–590. doi: 10.1080/08958378.2016.1236157. [DOI] [PubMed] [Google Scholar]
57.Perez L, Wolf K, Hennig F, Penell J, Basagana X, Foraster M, et al. Air pollution and atherosclerosis: a cross-sectional analysis of four European cohort studies in the ESCAPE study. Environ Health Perspect. 2015;123(6):597–605. doi: 10.1289/ehp.1307711. [DOI] [PMC free article] [PubMed] [Google Scholar]
58.Hartiala J, Breton CV, Tang WH, Lurmann F, Hazen SL, Gilliland FD, et al. Ambient Air Pollution Is Associated With the Severity of Coronary Atherosclerosis and Incident Myocardial Infarction in Patients Undergoing Elective Cardiac Evaluation. J Am Heart Assoc. 2016;5:8. doi: 10.1161/jaha.116.003947. [DOI] [PMC free article] [PubMed] [Google Scholar]
59.Kalsch H, Hennig F, Moebus S, Mohlenkamp S, Dragano N, Jakobs H, et al. Are air pollution and traffic noise independently associated with atherosclerosis: the Heinz Nixdorf Recall Study. Eur Heart J. 2014;35(13):853–860. doi: 10.1093/eurheartj/eht426. [DOI] [PubMed] [Google Scholar]
60.Kaufman JD, Adar SD, Barr RG, Budoff M, Burke GL, Curl CL, et al. Association between air pollution and coronary artery calcification within six metropolitan areas in the USA (the Multi-Ethnic Study of Atherosclerosis and Air Pollution): a longitudinal cohort study. Lancet. 2016;388(10045):696–704. doi: 10.1016/s0140-6736(16)00378-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
61.Ranzani OT, Mila C, Sanchez M, Bhogadi S, Kulkarni B, Balakrishnan K, et al. Association between ambient and household air pollution with carotid intima-media thickness in peri-urban South India: CHAI-Project. Int J Epidemiol. 2020;49(1):69–79. doi: 10.1093/ije/dyz208. [DOI] [PMC free article] [PubMed] [Google Scholar]
62.Akintoye E, Shi L, Obaitan I, Olusunmade M, Wang Y, Newman JD, et al. Association between fine particulate matter exposure and subclinical atherosclerosis: A meta-analysis. Eur J Prev Cardiol. 2016;23(6):602–612. doi: 10.1177/2047487315588758. [DOI] [PMC free article] [PubMed] [Google Scholar]
63.Bell G, Mora S, Greenland P, Tsai M, Gill E, Kaufman JD. Association of Air Pollution Exposures With High-Density Lipoprotein Cholesterol and Particle Number: The Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol. 2017;37(5):976–982. doi: 10.1161/atvbaha.116.308193. [DOI] [PMC free article] [PubMed] [Google Scholar]
64.Wu S, Yang D, Wei H, Wang B, Huang J, Li H, et al. Association of chemical constituents and pollution sources of ambient fine particulate air pollution and biomarkers of oxidative stress associated with atherosclerosis: A panel study among young adults in Beijing, China. Chemosphere. 2015;135:347–353. doi: 10.1016/j.chemosphere.2015.04.096. [DOI] [PubMed] [Google Scholar]
65.Wang M, Hou ZH, Xu H, Liu Y, Budoff MJ, Szpiro AA, et al. Association of Estimated Long-term Exposure to Air Pollution and Traffic Proximity With a Marker for Coronary Atherosclerosis in a Nationwide Study in China. JAMA Net Open. 2019;2(6):e196553. doi: 10.1001/jamanetworkopen.2019.6553. [DOI] [PMC free article] [PubMed] [Google Scholar]
66.Su TC, Hwang JJ, Shen YC, Chan CC. Carotid Intima-Media Thickness and Long-Term Exposure to Traffic-Related Air Pollution in Middle-Aged Residents of Taiwan: A Cross-Sectional Study. Environ Health Perspect. 2015;123(8):773–778. doi: 10.1289/ehp.1408553. [DOI] [PMC free article] [PubMed] [Google Scholar]
67.Ramanathan G, Yin F, Speck M, Tseng CH, Brook JR, Silverman F, et al. Effects of urban fine particulate matter and ozone on HDL functionality. Part Fibre Toxicol. 2016;13(1):26. doi: 10.1186/s12989-016-0139-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
68.Adar SD, Sheppard L, Vedal S, Polak JF, Sampson PD, Diez Roux AV, et al. Fine particulate air pollution and the progression of carotid intima-medial thickness: a prospective cohort study from the multi-ethnic study of atherosclerosis and air pollution. PLoS Med. 2013;10(4):e1001430. doi: 10.1371/journal.pmed.1001430. [DOI] [PMC free article] [PubMed] [Google Scholar]
69.Kim SY, Sheppard L, Kaufman JD, Bergen S, Szpiro AA, Larson TV, et al. Individual-level concentrations of fine particulate matter chemical components and subclinical atherosclerosis: a cross-sectional analysis based on 2 advanced exposure prediction models in the multi-ethnic study of atherosclerosis. Am J Epidemiol. 2014;180(7):718–728. doi: 10.1093/aje/kwu186. [DOI] [PMC free article] [PubMed] [Google Scholar]
70.Tonne C, Salmon M, Sanchez M, Sreekanth V, Bhogadi S, Sambandam S, et al. Integrated assessment of exposure to PM2.5 in South India and its relation with cardiovascular risk: Design of the CHAI observational cohort study. Int J Hyg Environ Health. 2017;220(6):1081–1088. doi: 10.1016/j.ijheh.2017.05.005. [DOI] [PubMed] [Google Scholar]
71.Hennig F, Moebus S, Reinsch N, Budde T, Erbel R, Jockel KH, et al. Investigation of air pollution and noise on progression of thoracic aortic calcification: results of the Heinz Nixdorf Recall Study. Eur J Prev Cardiol. 2019:2047487319854818. 10.1177/2047487319854818. [DOI] [PMC free article] [PubMed]
72.Gondalia R, Holliday KM, Baldassari A, Justice AE, Stewart JD, Liao D, et al. Leukocyte Traits and Exposure to Ambient Particulate Matter Air Pollution in the Women's Health Initiative and Atherosclerosis Risk in Communities Study. Environ Health Perspect. 2020;128(1):17004. doi: 10.1289/ehp5360. [DOI] [PMC free article] [PubMed] [Google Scholar]
73.Lenters V, Uiterwaal CS, Beelen R, Bots ML, Fischer P, Brunekreef B, et al. Long-term exposure to air pollution and vascular damage in young adults. Epidemiology. 2010;21(4):512–520. doi: 10.1097/EDE.0b013e3181dec3a7. [DOI] [PubMed] [Google Scholar]
74.O'Neill MS, Diez-Roux AV, Auchincloss AH, Shen M, Lima JA, Polak JF, et al. Long-term exposure to airborne particles and arterial stiffness: the Multi-Ethnic Study of Atherosclerosis (MESA) Environ Health Perspect. 2011;119(6):844–851. doi: 10.1289/ehp.0901524. [DOI] [PMC free article] [PubMed] [Google Scholar]
75.Huynh Q, Marwick TH, Venkataraman P, Knibbs LD, Johnston FH, Negishi K. Long-term exposure to ambient air pollution is associated with coronary artery calcification among asymptomatic adults. Eur Heart J Cardiovasc Imaging. 2020. 10.1093/ehjci/jeaa073. [DOI] [PubMed]
76.Fuks K, Moebus S, Hertel S, Viehmann A, Nonnemacher M, Dragano N, et al. Long-term urban particulate air pollution, traffic noise, and arterial blood pressure. Environ Health Perspect. 2011;119(12):1706–1711. doi: 10.1289/ehp.1103564. [DOI] [PMC free article] [PubMed] [Google Scholar]
77.Aguilera I, Dratva J, Caviezel S, Burdet L, de Groot E, Ducret-Stich RE, et al. Particulate Matter and Subclinical Atherosclerosis: Associations between Different Particle Sizes and Sources with Carotid Intima-Media Thickness in the SAPALDIA Study. Environ Halth Perspect. 2016;124(11):1700–1706. doi: 10.1289/ehp161. [DOI] [PMC free article] [PubMed] [Google Scholar]
78.Sun M, Kaufman JD, Kim SY, Larson TV, Gould TR, Polak JF, et al. Particulate matter components and subclinical atherosclerosis: common approaches to estimating exposure in a Multi-Ethnic Study of Atherosclerosis cross-sectional study. Environ Health. 2013;12:39. doi: 10.1186/1476-069x-12-39. [DOI] [PMC free article] [PubMed] [Google Scholar]
79.Yang S, Lee SP, Park JB, Lee H, Kang SH, Lee SE, et al. PM2.5 concentration in the ambient air is a risk factor for the development of high-risk coronary plaques. Eur Heart J Cardiovasc Imaging. 2019;20(12):1355–1364. doi: 10.1093/ehjci/jez209. [DOI] [PubMed] [Google Scholar]
80.Duan C, Talbott EO, Broadwin R, Brooks M, Matthews K, Barinas-Mitchell E. Residential Exposure to PM2.5 and Ozone and Progression of Subclinical Atherosclerosis Among Women Transitioning Through Menopause: The Study of Women's Health Across the Nation. J Women's Health. 2019;28(6):802–811. doi: 10.1089/jwh.2018.7182. [DOI] [PMC free article] [PubMed] [Google Scholar]
81.Hoffmann B, Moebus S, Mohlenkamp S, Stang A, Lehmann N, Dragano N, et al. Residential exposure to traffic is associated with coronary atherosclerosis. Circulation. 2007;116(5):489–496. doi: 10.1161/circulationaha.107.693622. [DOI] [PubMed] [Google Scholar]
82.Dorans KS, Wilker EH, Li W, Rice MB, Ljungman PL, Schwartz J, et al. Residential proximity to major roads, exposure to fine particulate matter and aortic calcium: the Framingham Heart Study, a cohort study. BMJ Open. 2017;7(3):e013455. doi: 10.1136/bmjopen-2016-013455. [DOI] [PMC free article] [PubMed] [Google Scholar]
83.Zhang Z, Chang LY, Lau AKH, Chan TC, Chieh Chuang Y, Chan J, et al. Satellite-based estimates of long-term exposure to fine particulate matter are associated with C-reactive protein in 30 034 Taiwanese adults. Int J Epidemiol. 2017;46(4):1126–1136. doi: 10.1093/ije/dyx069. [DOI] [PMC free article] [PubMed] [Google Scholar]
84.Breton CV, Wang X, Mack WJ, Berhane K, Lopez M, Islam TS, et al. Childhood air pollutant exposure and carotid artery intima-media thickness in young adults. Circulation. 2012;126(13):1614–1620. doi: 10.1161/circulationaha.112.096164. [DOI] [PMC free article] [PubMed] [Google Scholar]
85.Duan C, Talbott E, Brooks M, Park SK, Broadwin R, Matthews K, et al. Five-year exposure to PM(2.5) and ozone and subclinical atherosclerosis in late midlife women: The Study of Women's Health Across the Nation. Int J Hyg Environ Health. 2019;222(2):168–176. doi: 10.1016/j.ijheh.2018.09.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
86.Bauer M, Moebus S, Möhlenkamp S, Dragano N, Nonnemacher M, Fuchsluger M, et al. Urban particulate matter air pollution is associated with subclinical atherosclerosis: results from the HNR (Heinz Nixdorf Recall) study. J Am Coll Cardiol. 2010;56(22):1803–1808. doi: 10.1016/j.jacc.2010.04.065. [DOI] [PubMed] [Google Scholar]
87.Baumgartner J, Carter E, Schauer JJ, Ezzati M, Daskalopoulou SS, Valois MF, et al. Household air pollution and measures of blood pressure, arterial stiffness and central haemodynamics. Heart. 2018;104(18):1515–1521. doi: 10.1136/heartjnl-2017-312595. [DOI] [PubMed] [Google Scholar]
88.Painschab MS, Davila-Roman VG, Gilman RH, Vasquez-Villar AD, Pollard SL, Wise RA, et al. Chronic exposure to biomass fuel is associated with increased carotid artery intima-media thickness and a higher prevalence of atherosclerotic plaque. Heart. 2013;99(14):984–991. doi: 10.1136/heartjnl-2012-303440. [DOI] [PMC free article] [PubMed] [Google Scholar]
89.Künzli N, Jerrett M, Mack WJ, Beckerman B, LaBree L, Gilliland F, et al. Ambient air pollution and atherosclerosis in Los Angeles. Environ Health Perspect. 2005;113(2):201–206. doi: 10.1289/ehp.7523. [DOI] [PMC free article] [PubMed] [Google Scholar]
90.Allen RW, Criqui MH, Diez Roux AV, Allison M, Shea S, Detrano R, et al. Fine particulate matter air pollution, proximity to traffic, and aortic atherosclerosis. Epidemiology. 2009;20(2):254–264. doi: 10.1097/EDE.0b013e31819644cc. [DOI] [PMC free article] [PubMed] [Google Scholar]
91.Diez Roux AV, Auchincloss AH, Franklin TG, Raghunathan T, Barr RG, Kaufman J, et al. Long-term exposure to ambient particulate matter and prevalence of subclinical atherosclerosis in the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol. 2008;167(6):667–675. doi: 10.1093/aje/kwm359. [DOI] [PubMed] [Google Scholar]
92.Pang Y, Zhang B, Xing D, Shang J, Chen F, Kang H, et al. Increased risk of carotid atherosclerosis for long-term exposure to indoor coal-burning pollution in rural area, Hebei Province, China. Environ Pollut. 2019;255(Pt 2):113320. doi: 10.1016/j.envpol.2019.113320. [DOI] [PubMed] [Google Scholar]
93.Lee SH, Kim JH, Kang MJ, Lee YA, Won Yang S, Shin CH. Implications of nocturnal hypertension in children and adolescents with type 1 diabetes. Diabetes Care. 2011;34(10):2180–2185. doi: 10.2337/dc11-0830. [DOI] [PMC free article] [PubMed] [Google Scholar]
94.Du X, Jiang S, Zeng X, Zhang J, Pan K, Zhou J, et al. Air pollution is associated with the development of atherosclerosis via the cooperation of CD36 and NLRP3 inflammasome in ApoE(-/-) mice. Toxicol Lett. 2018;290:123–132. doi: 10.1016/j.toxlet.2018.03.022. [DOI] [PubMed] [Google Scholar]
95.Wan Q, Liu Z, Yang M, Wu J. Acceleratory effects of ambient fine particulate matter on the development and progression of atherosclerosis in apolipoprotein E knockout mice by down-regulating CD4(+)CD25(+)Foxp3(+) regulatory T cells. Toxicol Lett. 2019;316:27–34. doi: 10.1016/j.toxlet.2019.09.005. [DOI] [PubMed] [Google Scholar]
96.Wan Q, Cui X, Shao J, Zhou F, Jia Y, Sun X, et al. Beijing ambient particle exposure accelerates atherosclerosis in ApoE knockout mice by upregulating visfatin expression. Cell Stress Chaperones. 2014;19(5):715–724. doi: 10.1007/s12192-014-0499-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
97.Chen T, Jia G, Wei Y, Li J. Beijing ambient particle exposure accelerates atherosclerosis in ApoE knockout mice. Toxicol Lett. 2013;223(2):146–153. doi: 10.1016/j.toxlet.2013.09.004. [DOI] [PubMed] [Google Scholar]
98.Zhao J, Mi X, Zhao L, Midgley AC, Tang H, Tian M, et al. Validation of PM(2.5) model particle through physicochemical evaluation and atherosclerotic plaque formation in ApoE(-/-) mice. Ecotoxicol Environ Saf. 2020;192:110308. doi: 10.1016/j.ecoenv.2020.110308. [DOI] [PubMed] [Google Scholar]
99.Quan C, Sun Q, Lippmann M, Chen LC. Comparative effects of inhaled diesel exhaust and ambient fine particles on inflammation, atherosclerosis, and vascular dysfunction. Inhal Toxicol. 2010;22(9):738–753. doi: 10.3109/08958371003728057. [DOI] [PMC free article] [PubMed] [Google Scholar]
100.Wang S, Wang F, Yang L, Li Q, Huang Y, Cheng Z, et al. Effects of coal-fired PM(2.5) on the expression levels of atherosclerosis-related proteins and the phosphorylation level of MAPK in ApoE(-/-) mice. BMC Pharmacol Toxicol. 2020;21(1):34. doi: 10.1186/s40360-020-00411-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
101.Sun Q, Wang A, Jin X, Natanzon A, Duquaine D, Brook RD, et al. Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model. Jama. 2005;294(23):3003–3010. doi: 10.1001/jama.294.23.3003. [DOI] [PubMed] [Google Scholar]
102.Araujo JA, Barajas B, Kleinman M, Wang X, Bennett BJ, Gong KW, et al. Ambient particulate pollutants in the ultrafine range promote early atherosclerosis and systemic oxidative stress. Circ Res. 2008;102(5):589–596. doi: 10.1161/circresaha.107.164970. [DOI] [PMC free article] [PubMed] [Google Scholar]
103.Chen LC, Nadziejko C. Effects of subchronic exposures to concentrated ambient particles (CAPs) in mice. V. CAPs exacerbate aortic plaque development in hyperlipidemic mice. Inhal Toxicol. 2005;17(4-5):217–224. doi: 10.1080/08958370590912815. [DOI] [PubMed] [Google Scholar]
104.Zhu X, Zhao P, Lu Y, Huo L, Bai M, Yu F, et al. Potential injurious effects of the fine particulate PM2.5 on the progression of atherosclerosis in apoE-deficient mice by activating platelets and leukocytes. Arch Med Sci. 2019;15(1):250–261. doi: 10.5114/aoms.2018.81039. [DOI] [PMC free article] [PubMed] [Google Scholar]
105.Bai Y, Sun Q. Fine particulate matter air pollution and atherosclerosis: Mechanistic insights. Biochim Biophys Acta. 2016;1860(12):2863–2868. doi: 10.1016/j.bbagen.2016.04.030. [DOI] [PubMed] [Google Scholar]
106.Grahame TJ, Schlesinger RB. Oxidative stress-induced telomeric erosion as a mechanism underlying airborne particulate matter-related cardiovascular disease. Part Fibre Toxicol. 2012;9:21. doi: 10.1186/1743-8977-9-21. [DOI] [PMC free article] [PubMed] [Google Scholar]
107.Bourdrel T, Bind MA, Béjot Y, Morel O, Argacha JF. Cardiovascular effects of air pollution. Arch Cardiovasc Dis. 2017;110(11):634–642. doi: 10.1016/j.acvd.2017.05.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
108.Dai J, Chen W, Lin Y, Wang S, Guo X, Zhang QQ. Exposure to Concentrated Ambient Fine Particulate Matter Induces Vascular Endothelial Dysfunction via miR-21. Int J Biol Sci. 2017;13(7):868–877. doi: 10.7150/ijbs.19868. [DOI] [PMC free article] [PubMed] [Google Scholar]
109.Guo S, Som AT, Arai K, Lo EH. Effects of angiotensin-II on brain endothelial cell permeability via PPARalpha regulation of para- and trans-cellular pathways. Brain Res. 2019;1722:146353. doi: 10.1016/j.brainres.2019.146353. [DOI] [PMC free article] [PubMed] [Google Scholar]
110.Han W, Dan W, Shuo Y, Fang Z, Wenjun D. Oxidative stress induced by urban fine particles in cultured EA.hy926 cells. Hum Exp Toxicol. 2011;30(7):579–590. doi: 10.1177/0960327110374207. [DOI] [PubMed] [Google Scholar]
111.Wang Y, Tang M. PM2.5 induces autophagy and apoptosis through endoplasmic reticulum stress in human endothelial cells. Sci Total Environ. 2020;710:136397. doi: 10.1016/j.scitotenv.2019.136397. [DOI] [PubMed] [Google Scholar]
112.Wang Y, Tang M. PM2.5 induces ferroptosis in human endothelial cells through iron overload and redox imbalance. Environ Pollut. 2019;254(Pt A):112937. doi: 10.1016/j.envpol.2019.07.105. [DOI] [PubMed] [Google Scholar]
113.Sharma K, Lee HH, Gong DS, Park SH, Yi E, Schini-Kerth V, et al. Fine air pollution particles induce endothelial senescence via redox-sensitive activation of local angiotensin system. Environ Pollut. 2019;252(Pt A):317–329. doi: 10.1016/j.envpol.2019.05.066. [DOI] [PubMed] [Google Scholar]
114.Long YM, Yang XZ, Yang QQ, Clermont AC, Yin YG, Liu GL, et al. PM2.5 induces vascular permeability increase through activating MAPK/ERK signaling pathway and ROS generation. J Hazard Mater. 2020;386:121659. doi: 10.1016/j.jhazmat.2019.121659. [DOI] [PubMed] [Google Scholar]
115.Montiel-Dávalos A, Ibarra-Sánchez Mde J, Ventura-Gallegos JL, Alfaro-Moreno E, López-Marure R. Oxidative stress and apoptosis are induced in human endothelial cells exposed to urban particulate matter. Toxicol in Vitro. 2010;24(1):135–141. doi: 10.1016/j.tiv.2009.08.004. [DOI] [PubMed] [Google Scholar]
116.Xu X, Xu H, Qimuge A, Liu S, Wang H, Hu M, et al. MAPK/AP-1 pathway activation mediates AT1R upregulation and vascular endothelial cells dysfunction under PM2.5 exposure. Ecotoxicol Environ Saf. 2019;170:188–194. doi: 10.1016/j.ecoenv.2018.11.124. [DOI] [PubMed] [Google Scholar]
117.Chen S, Wu X, Hu J, Dai G, Rong A, Guo G. PM2.5 exposure decreases viability, migration and angiogenesis in human umbilical vein endothelial cells and human microvascular endothelial cells. Mol Med Rep. 2017;16 3:2425-2430; doi: 10.3892/mmr.2017.6877. [DOI] [PMC free article] [PubMed]
118.Rui W, Guan L, Zhang F, Zhang W, Ding W. PM2.5-induced oxidative stress increases adhesion molecules expression in human endothelial cells through the ERK/AKT/NF-kappaB-dependent pathway. J Appl Toxicol. 2016;36(1):48–59. doi: 10.1002/jat.3143. [DOI] [PubMed] [Google Scholar]
119.Zhu F, Cheng H, Lei R, Shen C, Liu J, Hou L, et al. Effects of cooking oil fume derived fine particulate matter on blood vessel formation through the VEGF/VEGFR2/MEK1/2/ERK1/2/mTOR pathway in human umbilical vein endothelial cells. Environ Toxicol Pharmacol. 2019;69:112–119. doi: 10.1016/j.etap.2019.04.008. [DOI] [PubMed] [Google Scholar]
120.Le Y, Hu X, Zhu J, Wang C, Yang Z, Lu D. Ambient fine particulate matter induces inflammatory responses of vascular endothelial cells through activating TLR-mediated pathway. Toxicol Ind Health. 2019;35(10):670–678. doi: 10.1177/0748233719871778. [DOI] [PubMed] [Google Scholar]
121.Yin J, Xia W, Li Y, Guo C, Zhang Y, Huang S, et al. COX-2 mediates PM2.5-induced apoptosis and inflammation in vascular endothelial cells. Am J Transl Res. 2017;9(9):3967–3976. [PMC free article] [PubMed] [Google Scholar]
122.Wang JS, Tseng CY, Chao MW. Diesel Exhaust Particles Contribute to Endothelia Apoptosis via Autophagy Pathway. Toxicol Sci. 2017;156(1):72–83. doi: 10.1093/toxsci/kfw237. [DOI] [PubMed] [Google Scholar]
123.Li R, Ning Z, Cui J, Yu F, Sioutas C, Hsiai T. Diesel exhaust particles modulate vascular endothelial cell permeability: implication of ZO-1 expression. Toxicol Lett. 2010;197(3):163–168. doi: 10.1016/j.toxlet.2010.05.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
124.Zhao J, Xie Y, Jiang R, Kan H, Song W. Effects of atorvastatin on fine particle-induced inflammatory response, oxidative stress and endothelial function in human umbilical vein endothelial cells. Hum Exp Toxicol. 2011;30(11):1828–1839. doi: 10.1177/0960327111401050. [DOI] [PubMed] [Google Scholar]
125.Lai CY, Lai CH, Chuang HC, Pan CH, Yen CC, Lin WY, et al. Physicochemistry and cardiovascular toxicity of metal fume PM2.5: a study of human coronary artery endothelial cells and welding workers. Sci Rep. 2016;6:33515. doi: 10.1038/srep33515. [DOI] [PMC free article] [PubMed] [Google Scholar]
126.Montiel-Dávalos A, Alfaro-Moreno E, López-Marure R. PM2.5 and PM10 induce the expression of adhesion molecules and the adhesion of monocytic cells to human umbilical vein endothelial cells. Inhal Toxicol. 2007;19(Suppl 1):91–98. doi: 10.1080/08958370701495212. [DOI] [PubMed] [Google Scholar]
127.Zhou Z, Shao T, Qin M, Miao X, Chang Y, Sheng W, et al. The effects of autophagy on vascular endothelial cells induced by airborne PM2.5. J Environ Sci. 2018;66:182–187. doi: 10.1016/j.jes.2017.05.019. [DOI] [PubMed] [Google Scholar]
128.Wang FF, Geng CM, Hao WD, Zhao YD, Li Q, Wang HM, et al. The Cellular Toxicity of PM2.5 Emitted from Coal Combustion in Human Umbilical Vein Endothelial Cells. Biomed Environ Sci. 2016;29(2):107–116. doi: 10.3967/bes2016.012. [DOI] [PubMed] [Google Scholar]
129.Wu S, Wang B, Yang D, Wei H, Li H, Pan L, et al. Ambient particulate air pollution and circulating antioxidant enzymes: A repeated-measure study in healthy adults in Beijing, China. Environ Pollut. 2016;208(Pt A):16–24. doi: 10.1016/j.envpol.2015.06.002. [DOI] [PubMed] [Google Scholar]
130.Feng B, Qi R, Gao J, Wang T, Xu H, Zhao Q, et al. Exercise training prevented endothelium dysfunction from particulate matter instillation in Wistar rats. Sci Total Environ. 2019;694:133674. doi: 10.1016/j.scitotenv.2019.133674. [DOI] [PubMed] [Google Scholar]
131.Kattoor AJ, Pothineni NVK, Palagiri D, Mehta JL. Oxidative Stress in Atherosclerosis. Curr Atheroscler Rep. 2017;19(11):42. doi: 10.1007/s11883-017-0678-6. [DOI] [PubMed] [Google Scholar]
132.Miao X, Li W, Niu B, Li J, Sun J, Qin M, et al. Mitochondrial dysfunction in endothelial cells induced by airborne fine particulate matter (<2.5 mum) J Appl Toxicol. 2019;39(10):1424–1432. doi: 10.1002/jat.3828. [DOI] [PubMed] [Google Scholar]
133.Kim D, Mouritzen U, Larsen BD, Roy S. Inhibition of Cx43 gap junction uncoupling prevents high glucose-induced apoptosis and reduces excess cell monolayer permeability in retinal vascular endothelial cells. Exp Eye Res. 2018;173:85–90. doi: 10.1016/j.exer.2018.05.003. [DOI] [PubMed] [Google Scholar]
134.Hennig B, Chow CK. Lipid peroxidation and endothelial cell injury: implications in atherosclerosis. Free Radic Biol Med. 1988;4(2):99–106. doi: 10.1016/0891-5849(88)90070-6. [DOI] [PubMed] [Google Scholar]
135.Krouwer VJ, Hekking LH, Langelaar-Makkinje M, Regan-Klapisz E, Post JA. Endothelial cell senescence is associated with disrupted cell-cell junctions and increased monolayer permeability. Vasc Cell. 2012;4(1):12. doi: 10.1186/2045-824x-4-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
136.Grimsley-Myers CM, Isaacson RH, Cadwell CM, Campos J, Hernandes MS, Myers KR, et al. VE-cadherin endocytosis controls vascular integrity and patterning during development. J Cell Biol. 2020;219:5. doi: 10.1083/jcb.201909081. [DOI] [PMC free article] [PubMed] [Google Scholar]
137.Wang T, Shimizu Y, Wu X, Kelly GT, Xu X, Wang L, et al. Particulate matter disrupts human lung endothelial cell barrier integrity via Rho-dependent pathways. Pulm Circ. 2017;7(3):617–623. doi: 10.1086/689906. [DOI] [PMC free article] [PubMed] [Google Scholar]
138.Giannotta M, Trani M, Dejana E. VE-cadherin and endothelial adherens junctions: active guardians of vascular integrity. Dev Cell. 2013;26(5):441–454. doi: 10.1016/j.devcel.2013.08.020. [DOI] [PubMed] [Google Scholar]
139.Marasciulo FL, Montagnani M, Potenza MA. Endothelin-1: the yin and yang on vascular function. Curr Med Chem. 2006;13(14):1655–1665. doi: 10.2174/092986706777441968. [DOI] [PubMed] [Google Scholar]
140.Niu J, Wu J, Li X, Zhang F. Association between endothelin-1/endothelin receptor A and inflammation in mouse kidneys following acute ischemia/reperfusion. Mol Med Rep. 2015;11(5):3981–3987. doi: 10.3892/mmr.2014.3138. [DOI] [PubMed] [Google Scholar]
141.Mazzuca MQ, Khalil RA. Vascular endothelin receptor type B: structure, function and dysregulation in vascular disease. Biochem Pharmacol. 2012;84(2):147–162. doi: 10.1016/j.bcp.2012.03.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
142.Gimbrone MA, Jr, Garcia-Cardena G. Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis. Circ Res. 2016;118(4):620–636. doi: 10.1161/circresaha.115.306301. [DOI] [PMC free article] [PubMed] [Google Scholar]
143.Deweirdt J, Quignard JF, Crobeddu B, Baeza-Squiban A, Sciare J, Courtois A, et al. Involvement of oxidative stress and calcium signaling in airborne particulate matter - induced damages in human pulmonary artery endothelial cells. Toxicol in Vitro. 2017;45(Pt 3):340–350. doi: 10.1016/j.tiv.2017.07.001. [DOI] [PubMed] [Google Scholar]
144.Xiao X, Cao L, Wang R, Shen ZX, Cao YX. Airborne fine particulate matter alters the expression of endothelin receptors in rat coronary arteries. Environ Pollut. 2016;218:487–496. doi: 10.1016/j.envpol.2016.07.028. [DOI] [PubMed] [Google Scholar]
145.Chan EA, Buckley B, Farraj AK, Thompson LC. The heart as an extravascular target of endothelin-1 in particulate matter-induced cardiac dysfunction. Pharmacol Ther. 2016;165:63–78. doi: 10.1016/j.pharmthera.2016.05.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
146.Lin YJ, Kwok CF, Juan CC, Hsu YP, Shih KC, Chen CC, et al. Angiotensin II enhances endothelin-1-induced vasoconstriction through upregulating endothelin type A receptor. Biochem Biophys Res Commun. 2014;451(2):263–269. doi: 10.1016/j.bbrc.2014.07.119. [DOI] [PubMed] [Google Scholar]
147.Haberzettl P, O'Toole TE, Bhatnagar A, Conklin DJ. Exposure to Fine Particulate Air Pollution Causes Vascular Insulin Resistance by Inducing Pulmonary Oxidative Stress. Environ Health Perspect. 2016;124(12):1830–1839. doi: 10.1289/ehp212. [DOI] [PMC free article] [PubMed] [Google Scholar]
148.Kim F, Pham M, Maloney E, Rizzo NO, Morton GJ, Wisse BE, et al. Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance. Arterioscler Thromb Vasc Biol. 2008;28(11):1982–1988. doi: 10.1161/atvbaha.108.169722. [DOI] [PMC free article] [PubMed] [Google Scholar]
149.Kim JA, Montagnani M, Koh KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation. 2006;113(15):1888–1904. doi: 10.1161/circulationaha.105.563213. [DOI] [PubMed] [Google Scholar]
150.Landmesser U, Hornig B, Drexler H. Endothelial function: a critical determinant in atherosclerosis? Circulation. 2004;109(21 Suppl 1):Ii27–Ii33. doi: 10.1161/01.CIR.0000129501.88485.1f. [DOI] [PubMed] [Google Scholar]
151.Bayraktutan U. Endothelial progenitor cells: Potential novel therapeutics for ischaemic stroke. Pharmacol Res. 2019;144:181–191. doi: 10.1016/j.phrs.2019.04.017. [DOI] [PubMed] [Google Scholar]
152.Noor R, Shuaib U, Wang CX, Todd K, Ghani U, Schwindt B, et al. High-density lipoprotein cholesterol regulates endothelial progenitor cells by increasing eNOS and preventing apoptosis. Atherosclerosis. 2007;192(1):92–99. doi: 10.1016/j.atherosclerosis.2006.06.023. [DOI] [PubMed] [Google Scholar]
153.Haberzettl P, Conklin DJ, Abplanalp WT, Bhatnagar A, O'Toole TE. Inhalation of Fine Particulate Matter Impairs Endothelial Progenitor Cell Function Via Pulmonary Oxidative Stress. Arterioscler Thromb Vasc Biol. 2018;38(1):131–142. doi: 10.1161/atvbaha.117.309971. [DOI] [PMC free article] [PubMed] [Google Scholar]
154.Haberzettl P, McCracken JP, Bhatnagar A, Conklin DJ. Insulin sensitizers prevent fine particulate matter-induced vascular insulin resistance and changes in endothelial progenitor cell homeostasis. Am J Physiol Heart Circ Physiol. 2016;310(11):H1423–H1438. doi: 10.1152/ajpheart.00369.2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
155.Cui Y, Sun Q, Liu Z. Ambient particulate matter exposure and cardiovascular diseases: a focus on progenitor and stem cells. J Cell Mol Med. 2016;20(5):782–793. doi: 10.1111/jcmm.12822. [DOI] [PMC free article] [PubMed] [Google Scholar]
156.Jian D, Wang W, Zhou X, Jia Z, Wang J, Yang M, et al. Interferon-induced protein 35 inhibits endothelial cell proliferation, migration and re-endothelialization of injured arteries by inhibiting the nuclear factor-kappa B pathway. Acta Physiol (Ox) 2018;223(3):e13037. doi: 10.1111/apha.13037. [DOI] [PubMed] [Google Scholar]
157.Robertson S, Miller MR. Ambient air pollution and thrombosis. Part Fibre Toxicol. 2018;15(1):1. doi: 10.1186/s12989-017-0237-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
158.Esmon CT. Coagulation inhibitors in inflammation. Biochem Soc Trans. 2005;33(Pt 2):401–405. doi: 10.1042/bst0330401. [DOI] [PubMed] [Google Scholar]
159.Hu H, Wu J, Li Q, Asweto C, Feng L, Yang X, et al. Fine particulate matter induces vascular endothelial activation via IL-6 dependent JAK1/STAT3 signaling pathway. Toxicol Res. 2016;5(3):946–953. doi: 10.1039/c5tx00351b. [DOI] [PMC free article] [PubMed] [Google Scholar]
160.Liang S, Zhao T, Hu H, Shi Y, Xu Q, Miller MR, et al. Repeat dose exposure of PM2.5 triggers the disseminated intravascular coagulation (DIC) in SD rats. Sci Total Environ. 2019;663:245–253. doi: 10.1016/j.scitotenv.2019.01.346. [DOI] [PMC free article] [PubMed] [Google Scholar]
161.Kawecki C, Lenting PJ, Denis CV. von Willebrand factor and inflammation. J Thromb Haemost. 2017;15(7):1285–1294. doi: 10.1111/jth.13696. [DOI] [PubMed] [Google Scholar]
162.Lordan R, Tsoupras A, Zabetakis I. Platelet activation and prothrombotic mediators at the nexus of inflammation and atherosclerosis: Potential role of antiplatelet agents. Blood Rev. 2020;100694. 10.1016/j.blre.2020.100694. [DOI] [PubMed]
163.Ten Cate H, Hackeng TM, Garcia de Frutos P. Coagulation factor and protease pathways in thrombosis and cardiovascular disease. Thromb Haemost. 2017;117(7):1265–1271. doi: 10.1160/th17-02-0079. [DOI] [PubMed] [Google Scholar]
164.Liu C, Cai J, Qiao L, Wang H, Xu W, Li H, et al. The Acute Effects of Fine Particulate Matter Constituents on Blood Inflammation and Coagulation. Environ Sci Technol. 2017;51(14):8128–8137. doi: 10.1021/acs.est.7b00312. [DOI] [PubMed] [Google Scholar]
165.Libby P, Buring JE, Badimon L, Hansson GK, Deanfield J, Bittencourt MS, et al. Atherosclerosis. Nature reviews Disease primers. 2019;5 1:56; doi: 10.1038/s41572-019-0106-z. [DOI] [PubMed]
166.Tabas I, Bornfeldt KE. Intracellular and Intercellular Aspects of Macrophage Immunometabolism in Atherosclerosis. Circ Res. 2020;126(9):1209–1227. doi: 10.1161/circresaha.119.315939. [DOI] [PMC free article] [PubMed] [Google Scholar]
167.Goldberg AC, Leiter LA, Stroes ESG, Baum SJ, Hanselman JC, Bloedon LT, et al. Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease: The CLEAR Wisdom Randomized Clinical Trial. Jama. 2019;322(18):1780–1788. doi: 10.1001/jama.2019.16585. [DOI] [PMC free article] [PubMed] [Google Scholar]
168.Hansson GK, Jonasson L. The discovery of cellular immunity in the atherosclerotic plaque. Arterioscler Thromb Vasc Biol. 2009;29(11):1714–1717. doi: 10.1161/atvbaha.108.179713. [DOI] [PubMed] [Google Scholar]
169.Huang L, Chambliss KL, Gao X, Yuhanna IS, Behling-Kelly E, Bergaya S, et al. SR-B1 drives endothelial cell LDL transcytosis via DOCK4 to promote atherosclerosis. Nature. 2019;569(7757):565–569. doi: 10.1038/s41586-019-1140-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
170.Mehta JL, Chen J, Hermonat PL, Romeo F, Novelli G. Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders. Cardiovasc Res. 2006;69(1):36–45. doi: 10.1016/j.cardiores.2005.09.006. [DOI] [PubMed] [Google Scholar]
171.Li D, Mehta JL. Intracellular signaling of LOX-1 in endothelial cell apoptosis. Circ Res. 2009;104(5):566–568. doi: 10.1161/circresaha.109.194209. [DOI] [PubMed] [Google Scholar]
172.Akhmedov A, Rozenberg I, Paneni F, Camici GG, Shi Y, Doerries C, et al. Endothelial overexpression of LOX-1 increases plaque formation and promotes atherosclerosis in vivo. Eur Heart J. 2014;35(40):2839–2848. doi: 10.1093/eurheartj/eht532. [DOI] [PubMed] [Google Scholar]
173.Markstad H, Edsfeldt A, Yao Mattison I, Bengtsson E, Singh P, Cavalera M, et al. High Levels of Soluble Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 Are Associated With Carotid Plaque Inflammation and Increased Risk of Ischemic Stroke. J Ame Heart Assoc. 2019;8(4):e009874. doi: 10.1161/JAHA.118.009874. [DOI] [PMC free article] [PubMed] [Google Scholar]
174.Lund AK, Lucero J, Harman M, Madden MC, McDonald JD, Seagrave JC, et al. The oxidized low-density lipoprotein receptor mediates vascular effects of inhaled vehicle emissions. Am J Respir Crit Care Med. 2011;184(1):82–91. doi: 10.1164/rccm.201012-1967OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
175.Kodavanti UP, Thomas R, Ledbetter AD, Schladweiler MC, Shannahan JH, Wallenborn JG, et al. Vascular and cardiac impairments in rats inhaling ozone and diesel exhaust particles. Environ Health Perspect. 2011;119(3):312–318. doi: 10.1289/ehp.1002386. [DOI] [PMC free article] [PubMed] [Google Scholar]
176.Lucero J, Suwannasual U, Herbert LM, McDonald JD, Lund AK. The role of the lectin-like oxLDL receptor (LOX-1) in traffic-generated air pollution exposure-mediated alteration of the brain microvasculature in Apolipoprotein (Apo) E knockout mice. Inhal Toxicol. 2017;29(6):266–281. doi: 10.1080/08958378.2017.1357774. [DOI] [PMC free article] [PubMed] [Google Scholar]
177.Liu J, Liang S, Du Z, Zhang J, Sun B, Zhao T, et al. PM2.5 aggravates the lipid accumulation, mitochondrial damage and apoptosis in macrophage foam cells. Environ Pollut. 2019;249:482–490. doi: 10.1016/j.envpol.2019.03.045. [DOI] [PubMed] [Google Scholar]
178.WHO, Burden of disease from the joint effects of household and ambient air pollution. 2018, Available from: www.who.int/airpollution/data/.
179.Brauner EV, Forchhammer L, Moller P, Barregard L, Gunnarsen L, Afshari A, et al. Indoor particles affect vascular function in the aged: an air filtration-based intervention study. Am J Respir Crit Care Med. 2008;177(4):419–425. doi: 10.1164/rccm.200704-632OC. [DOI] [PubMed] [Google Scholar]
180.Ding R, Zhang C, Zhu X, Cheng H, Zhu F, Xu Y, et al. ROS-AKT-mTOR axis mediates autophagy of human umbilical vein endothelial cells induced by cooking oil fumes-derived fine particulate matters in vitro. Free Radic Biol Med. 2017;113:452–460. doi: 10.1016/j.freeradbiomed.2017.10.386. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Databases/repositories and materials is not applicable in this review.

[CR1] 1.Mannucci PM, Harari S, Franchini M. Novel evidence for a greater burden of ambient air pollution on cardiovascular disease. Haematologica. 2019;104(12):2349–2357. doi: 10.3324/haematol.2019.225086. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR2] 2.Benziger CP, Roth GA, Moran AE. The Global Burden of Disease Study and the Preventable Burden of NCD. Glob Heart. 2016;11(4):393–397. doi: 10.1016/j.gheart.2016.10.024. [DOI] [PubMed] [Google Scholar]

[CR3] 3.Cohen AJ, Brauer M, Burnett R, Anderson HR, Frostad J, Estep K, et al. Estimates and 25-year trends of the global burden of disease attributable to ambient air pollution: an analysis of data from the Global Burden of Diseases Study 2015. Lancet. 2017;389(10082):1907–1918. doi: 10.1016/s0140-6736(17)30505-6. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR4] 4.Liang CS, Duan FK, He KB, Ma YL. Review on recent progress in observations, source identifications and countermeasures of PM2.5. Environ Int. 2016;86:150–170. doi: 10.1016/j.envint.2015.10.016. [DOI] [PubMed] [Google Scholar]

[CR5] 5.Walter CM, Schneider-Futschik EK, Knibbs LD, Irving LB. Health impacts of bushfire smoke exposure in Australia. Respirology. 2020. 10.1111/resp.13798. [DOI] [PubMed]

[CR6] 6.Zhang J, Liang S, Ning R, Jiang J, Zhang J, Shen H, et al. PM2.5-induced inflammation and lipidome alteration associated with the development of atherosclerosis based on a targeted lipidomic analysis. Environ Int. 2020;136:105444. doi: 10.1016/j.envint.2019.105444. [DOI] [PubMed] [Google Scholar]

[CR7] 7.Park SK, Auchincloss AH, O'Neill MS, Prineas R, Correa JC, Keeler J, et al. Particulate air pollution, metabolic syndrome, and heart rate variability: the multi-ethnic study of atherosclerosis (MESA) Environ Health Perspect. 2010;118(10):1406–1411. doi: 10.1289/ehp.0901778. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR8] 8.Brook RD, Rajagopalan S, Pope CA, 3rd, Brook JR, Bhatnagar A, Diez-Roux AV, et al. Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation. 2010;121(21):2331–2378. doi: 10.1161/CIR.0b013e3181dbece1. [DOI] [PubMed] [Google Scholar]

[CR9] 9.Jiang Y, Lu H, Man Q, Liu Z, Wang L, Wang Y, et al. Stroke burden and mortality attributable to ambient fine particulate matter pollution in 195 countries and territories and trend analysis from 1990 to 2017. Environ Res. 2020;184:109327. doi: 10.1016/j.envres.2020.109327. [DOI] [PubMed] [Google Scholar]

[CR10] 10.Zhu YH, Xian XM, Wang ZZ, Bi YC, Chen QG, Han XF, et al. Research Progress on the Relationship between Atherosclerosis and Inflammation. Biomolecules. 2018;8:3. doi: 10.3390/biom8010003. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR11] 11.Bäck M, Yurdagul A, Jr, Tabas I, Öörni K, Kovanen PT. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities. Nat Rev Cardiol. 2019;16(7):389–406. doi: 10.1038/s41569-019-0169-2. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR12] 12.Rao X, Zhong J, Maiseyeu A, Gopalakrishnan B, Villamena FA, Chen LC, et al. CD36-dependent 7-ketocholesterol accumulation in macrophages mediates progression of atherosclerosis in response to chronic air pollution exposure. Circ Res. 2014;115(9):770–780. doi: 10.1161/circresaha.115.304666. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR13] 13.Mueller PA, Zhu L, Tavori H, Huynh K, Giunzioni I, Stafford JM, et al. Deletion of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Accelerates Atherosclerosis Regression and Increases C-C Chemokine Receptor Type 7 (CCR7) Expression in Plaque Macrophages. Circulation. 2018;138(17):1850–1863. doi: 10.1161/circulationaha.117.031702. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR14] 14.Tang SL, Chen WJ, Yin K, Zhao GJ, Mo ZC, Lv YC, et al. PAPP-A negatively regulates ABCA1, ABCG1 and SR-B1 expression by inhibiting LXRα through the IGF-I-mediated signaling pathway. Atherosclerosis. 2012;222 2:344-354; doi: 10.1016/j.atherosclerosis.2012.03.005. [DOI] [PubMed]

[CR15] 15.Zeng Y, Peng Y, Tang K, Wang YQ, Zhao ZY, Wei XY, et al. Dihydromyricetin ameliorates foam cell formation via LXRα-ABCA1/ABCG1-dependent cholesterol efflux in macrophages. Biomed Pharmacother. 2018;101:543–552. doi: 10.1016/j.biopha.2018.02.124. [DOI] [PubMed] [Google Scholar]

[CR16] 16.Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011;473(7347):317–325. doi: 10.1038/nature10146. [DOI] [PubMed] [Google Scholar]

[CR17] 17.Gough PJ, Gomez IG, Wille PT, Raines EW. Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. J Clin Invest. 2006;116(1):59–69. doi: 10.1172/jci25074. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR18] 18.Saba L, Saam T, Jager HR, Yuan C, Hatsukami TS, Saloner D, et al. Imaging biomarkers of vulnerable carotid plaques for stroke risk prediction and their potential clinical implications. Lancet Neurol. 2019;18(6):559–572. doi: 10.1016/S1474-4422(19)30035-3. [DOI] [PubMed] [Google Scholar]

[CR19] 19.Sharkey J, Starkey Lewis PJ, Barrow M, Alwahsh SM, Noble J, Livingstone E, et al. Functionalized superparamagnetic iron oxide nanoparticles provide highly efficient iron-labeling in macrophages for magnetic resonance-based detection in vivo. Cytotherapy. 2017;19(4):555–569. doi: 10.1016/j.jcyt.2017.01.003. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR20] 20.Robson PM, Dweck MR, Trivieri MG, Abgral R, Karakatsanis NA, Contreras J, et al. Coronary Artery PET/MR Imaging: Feasibility, Limitations, and Solutions. JACC Cardiovasc Imaging. 2017;10(10 Pt A):1103–1112. doi: 10.1016/j.jcmg.2016.09.029. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR21] 21.Hop H, de Boer SA, Reijrink M, Kamphuisen PW, de Borst MH, Pol RA, et al. (18)F-sodium fluoride positron emission tomography assessed microcalcifications in culprit and non-culprit human carotid plaques. J Nucl Cardiol. 2019;26(4):1064–1075. doi: 10.1007/s12350-018-1325-5.. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR22] 22.Sundboll J, Larsen AP, Veres K, Adelborg K, Sorensen HT. Cardiovascular event rates and trajectories of LDL-cholesterol levels and lipid-lowering therapy in patients with atherosclerotic cardiovascular disease: A population-based cohort study. Thromb Res. 2019;183:124–130. doi: 10.1016/j.thromres.2019.09.034. [DOI] [PubMed] [Google Scholar]

[CR23] 23.Wang J, Geng NB, Xu YF, Zhang WD, Tang XY, Zhang RQ. PAHs in PM2.5 in Zhengzhou: concentration, carcinogenic risk analysis, and source apportionment. Environ Monit Assess. 2014;186(11):7461–7473. doi: 10.1007/s10661-014-3940-1. [DOI] [PubMed] [Google Scholar]

[CR24] 24.Hellén H, Hakola H, Haaparanta S, Pietarila H, Kauhaniemi M. Influence of residential wood combustion on local air quality. Sci Total Environ 2008;393 2-3:283-90; doi: 10.1016/j.scitotenv.2008.01.019. [DOI] [PubMed]

[CR25] 25.Miller MR, McLean SG, Duffin R, Lawal AO, Araujo JA, Shaw CA, et al. Diesel exhaust particulate increases the size and complexity of lesions in atherosclerotic mice. Part Fibre Toxicol. 2013;10:61. doi: 10.1186/1743-8977-10-61. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR26] 26.Pöss J, Lorenz D, Werner C, Pavlikova V, Gensch C, Speer T, et al. Diesel exhaust particles impair endothelial progenitor cells, compromise endothelial integrity, reduce neoangiogenesis, and increase atherogenesis in mice. Cardiovasc Toxicol. 2013;13(3):290–300. doi: 10.1007/s12012-013-9208-0. [DOI] [PubMed] [Google Scholar]

[CR27] 27.Brinchmann BC, Le Ferrec E, Podechard N, Lagadic-Gossmann D, Holme JA, Øvrevik J. Organic chemicals from diesel exhaust particles affects intracellular calcium, inflammation and β-adrenoceptors in endothelial cells. Toxicol Lett. 2019;302:18–27. doi: 10.1016/j.toxlet.2018.11.009. [DOI] [PubMed] [Google Scholar]

[CR28] 28.Holme JA, Brinchmann BC, Le Ferrec E, Lagadic-Gossmann D, Øvrevik J. Combustion Particle-Induced Changes in Calcium Homeostasis: A Contributing Factor to Vascular Disease? Cardiovasc Toxicol. 2019;19(3):198–209. doi: 10.1007/s12012-019-09518-9. [DOI] [PubMed] [Google Scholar]

[CR29] 29.Brinchmann BC, Skuland T, Rambøl MH, Szoke K, Brinchmann JE, Gutleb AC, et al. Lipophilic components of diesel exhaust particles induce pro-inflammatory responses in human endothelial cells through AhR dependent pathway(s) Part Fibre Toxicol. 2018;15(1):21. doi: 10.1186/s12989-018-0257-1. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR30] 30.Brinchmann BC, Le Ferrec E, Podechard N, Lagadic-Gossmann D, Shoji KF, Penna A. Lipophilic Chemicals from Diesel Exhaust Particles Trigger Calcium Response in Human Endothelial Cells via Aryl Hydrocarbon Receptor Non-Genomic Signalling. Intern J Mol Sci. 2018;19:5. 10.3390/ijms19051429. [DOI] [PMC free article] [PubMed]

[CR31] 31.Alshaarawy O, Elbaz HA, Andrew ME. The association of urinary polycyclic aromatic hydrocarbon biomarkers and cardiovascular disease in the US population. Environ Int. 2016;89-90:174-178; doi: 10.1016/j.envint.2016.02.006. [DOI] [PMC free article] [PubMed]

[CR32] 32.Manisalidis I, Stavropoulou E, Stavropoulos A, Bezirtzoglou E. Environmental and Health Impacts of Air Pollution: A Review. Front Public Health. 2020;8:14. doi: 10.3389/fpubh.2020.00014. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR33] 33.Munzel T, Gori T, Al-Kindi S, Deanfield J, Lelieveld J, Daiber A, et al. Effects of gaseous and solid constituents of air pollution on endothelial function. Eur Heart J. 2018;39(38):3543–3550. doi: 10.1093/eurheartj/ehy481. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR34] 34.Rao X, Zhong J, Brook RD, Rajagopalan S. Effect of Particulate Matter Air Pollution on Cardiovascular Oxidative Stress Pathways. Antioxid Redox Signal. 2018;28(9):797–818. doi: 10.1089/ars.2017.7394. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR35] 35.Zhang Q, Niu Y, Xia Y, Lei X, Wang W, Huo J, et al. The acute effects of fine particulate matter constituents on circulating inflammatory biomarkers in healthy adults. Sci Total Environ. 2020;707:135989. doi: 10.1016/j.scitotenv.2019.135989. [DOI] [PubMed] [Google Scholar]

[CR36] 36.Bekki K, Ito T, Yoshida Y, He C, Arashidani K, He M, et al. PM2.5 collected in China causes inflammatory and oxidative stress responses in macrophages through the multiple pathways. Environ Toxicol Pharmacol. 2016;45:362–369. doi: 10.1016/j.etap.2016.06.022. [DOI] [PubMed] [Google Scholar]

[CR37] 37.Pope CA, 3rd, Bhatnagar A, McCracken JP, Abplanalp W, Conklin DJ, O'Toole T. Exposure to Fine Particulate Air Pollution Is Associated With Endothelial Injury and Systemic Inflammation. Circ Res. 2016;119(11):1204–1214. doi: 10.1161/circresaha.116.309279. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR38] 38.Hajat A, Allison M, Diez-Roux AV, Jenny NS, Jorgensen NW, Szpiro AA, et al. Long-term exposure to air pollution and markers of inflammation, coagulation, and endothelial activation: a repeat-measures analysis in the Multi-Ethnic Study of Atherosclerosis (MESA) Epidemiology. 2015;26(3):310–320. doi: 10.1097/ede.0000000000000267. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR39] 39.Wu CF, Shen FH, Li YR, Tsao TM, Tsai MJ, Chen CC, et al. Association of short-term exposure to fine particulate matter and nitrogen dioxide with acute cardiovascular effects. Sci Total Environ. 2016;569-570:300–305. doi: 10.1016/j.scitotenv.2016.06.084. [DOI] [PubMed] [Google Scholar]

[CR40] 40.Shen C, Liu J, Zhu F, Lei R, Cheng H, Zhang C, et al. The effects of cooking oil fumes-derived PM2.5 on blood vessel formation through ROS-mediated NLRP3 inflammasome pathway in human umbilical vein endothelial cells. Ecotoxicol Environ Saf. 2019;174:690–698. doi: 10.1016/j.ecoenv.2019.03.028. [DOI] [PubMed] [Google Scholar]

[CR41] 41.Soppa VJ, Shinnawi S, Hennig F, Sasse B, Hellack B, Kaminski H, et al. Effects of short-term exposure to fine and ultrafine particles from indoor sources on arterial stiffness - A randomized sham-controlled exposure study. Int J Hyg Environ Health. 2019;222(8):1115–1132. doi: 10.1016/j.ijheh.2019.08.002. [DOI] [PubMed] [Google Scholar]

[CR42] 42.Pate M, Damarla V, Chi DS, Negi S, Krishnaswamy G. Endothelial cell biology: role in the inflammatory response. Adv Cin Chem. 2010;52:109–130. doi: 10.1016/S0065-2423(10)52004-3. [DOI] [PubMed] [Google Scholar]

[CR43] 43.Brook RD, Brook JR, Urch B, Vincent R, Rajagopalan S, Silverman F. Inhalation of fine particulate air pollution and ozone causes acute arterial vasoconstriction in healthy adults. Circulation. 2002;105(13):1534–1536. doi: 10.1161/01.cir.0000013838.94747.64. [DOI] [PubMed] [Google Scholar]

[CR44] 44.Daiber A, Steven S, Weber A, Shuvaev VV, Muzykantov VR, Laher I, et al. Targeting vascular (endothelial) dysfunction. Br J Pharmacol. 2017;174(12):1591–1619. doi: 10.1111/bph.13517. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR45] 45.Lawal AO, Davids LM, Marnewick JL. Diesel exhaust particles and endothelial cells dysfunction: An update. Toxicol in Vitro. 2016;32:92–104. doi: 10.1016/j.tiv.2015.12.015. [DOI] [PubMed] [Google Scholar]

[CR46] 46.Fang X, Li R, Xu Q, Bottai M, Fang F, Cao Y. A Two-Stage Method to Estimate the Contribution of Road Traffic to PM(2).(5) Concentrations in Beijing, China. Int J Environ Res Public Health. 2016;13:1. doi: 10.3390/ijerph13010124. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR47] 47.Ito K, Xue N, Thurston GJAE. Spatial variation of PM2.5 chemical species and source-apportioned mass concentrations in New York City. Atmos Environ. 2004;38(31):5269–5282. doi: 10.1016/j.atmosenv.2004.02.063. [DOI] [Google Scholar]

[CR48] 48.Chuersuwan N, Nimrat S, Lekphet S, Kerdkumrai T. Levels and major sources of PM2.5 and PM10 in Bangkok Metropolitan Region. Environ Int. 2008;34(5):671–677. doi: 10.1016/j.envint.2007.12.018. [DOI] [PubMed] [Google Scholar]

[CR49] 49.Miller MR, Newby DE. Air pollution and cardiovascular disease: car sick. Cardiovasc Res. 2020;116(2):279–294. doi: 10.1093/cvr/cvz228. [DOI] [PubMed] [Google Scholar]

[CR50] 50.Choi SH, Harkewicz R, Lee JH, Boullier A, Almazan F, Li AC, et al. Lipoprotein accumulation in macrophages via toll-like receptor-4-dependent fluid phase uptake. Circ Res. 2009;104(12):1355–1363. doi: 10.1161/circresaha.108.192880. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR51] 51.Geng J, Liu H, Ge P, Hu T, Zhang Y, Zhang X, et al. PM2.5 promotes plaque vulnerability at different stages of atherosclerosis and the formation of foam cells via TLR4/MyD88/NFkappaB pathway. Ecotoxicol Environ Saf. 2019;176:76–84. doi: 10.1016/j.ecoenv.2019.03.068. [DOI] [PubMed] [Google Scholar]

[CR52] 52.Liu J, Liang S, Du Z, Zhang J, Sun B, Zhao T, et al. PM(2.5) aggravates the lipid accumulation, mitochondrial damage and apoptosis in macrophage foam cells. Environ Pollut. 2019;249:482–490. doi: 10.1016/j.envpol.2019.03.045. [DOI] [PubMed] [Google Scholar]

[CR53] 53.Holme SAN, Sigsgaard T. Effects of particulate matter on atherosclerosis: a link via high-density lipoprotein (HDL) functionality? Part Fibre Toxicol. 2020;17(1):36. doi: 10.1186/s12989-020-00367-x. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR54] 54.Doran AC, Yurdagul A, Jr, Tabas I. Efferocytosis in health and disease. Nat Rev Immunol. 2020;20(4):254–267. doi: 10.1038/s41577-019-0240-6. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR55] 55.Wan Q, Liu Z, Yang Y. Puerarin inhibits vascular smooth muscle cells proliferation induced by fine particulate matter via suppressing of the p38 MAPK signaling pathway. BMC Complement Altern Med. 2018;18(1):146. doi: 10.1186/s12906-018-2206-9. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR56] 56.Cao Y, Long J, Ji Y, Chen G, Shen Y, Gong Y, et al. Foam cell formation by particulate matter (PM) exposure: a review. Inhal Toxicol. 2016;28(13):583–590. doi: 10.1080/08958378.2016.1236157. [DOI] [PubMed] [Google Scholar]

[CR57] 57.Perez L, Wolf K, Hennig F, Penell J, Basagana X, Foraster M, et al. Air pollution and atherosclerosis: a cross-sectional analysis of four European cohort studies in the ESCAPE study. Environ Health Perspect. 2015;123(6):597–605. doi: 10.1289/ehp.1307711. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR58] 58.Hartiala J, Breton CV, Tang WH, Lurmann F, Hazen SL, Gilliland FD, et al. Ambient Air Pollution Is Associated With the Severity of Coronary Atherosclerosis and Incident Myocardial Infarction in Patients Undergoing Elective Cardiac Evaluation. J Am Heart Assoc. 2016;5:8. doi: 10.1161/jaha.116.003947. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR59] 59.Kalsch H, Hennig F, Moebus S, Mohlenkamp S, Dragano N, Jakobs H, et al. Are air pollution and traffic noise independently associated with atherosclerosis: the Heinz Nixdorf Recall Study. Eur Heart J. 2014;35(13):853–860. doi: 10.1093/eurheartj/eht426. [DOI] [PubMed] [Google Scholar]

[CR60] 60.Kaufman JD, Adar SD, Barr RG, Budoff M, Burke GL, Curl CL, et al. Association between air pollution and coronary artery calcification within six metropolitan areas in the USA (the Multi-Ethnic Study of Atherosclerosis and Air Pollution): a longitudinal cohort study. Lancet. 2016;388(10045):696–704. doi: 10.1016/s0140-6736(16)00378-0. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR61] 61.Ranzani OT, Mila C, Sanchez M, Bhogadi S, Kulkarni B, Balakrishnan K, et al. Association between ambient and household air pollution with carotid intima-media thickness in peri-urban South India: CHAI-Project. Int J Epidemiol. 2020;49(1):69–79. doi: 10.1093/ije/dyz208. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR62] 62.Akintoye E, Shi L, Obaitan I, Olusunmade M, Wang Y, Newman JD, et al. Association between fine particulate matter exposure and subclinical atherosclerosis: A meta-analysis. Eur J Prev Cardiol. 2016;23(6):602–612. doi: 10.1177/2047487315588758. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR63] 63.Bell G, Mora S, Greenland P, Tsai M, Gill E, Kaufman JD. Association of Air Pollution Exposures With High-Density Lipoprotein Cholesterol and Particle Number: The Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol. 2017;37(5):976–982. doi: 10.1161/atvbaha.116.308193. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR64] 64.Wu S, Yang D, Wei H, Wang B, Huang J, Li H, et al. Association of chemical constituents and pollution sources of ambient fine particulate air pollution and biomarkers of oxidative stress associated with atherosclerosis: A panel study among young adults in Beijing, China. Chemosphere. 2015;135:347–353. doi: 10.1016/j.chemosphere.2015.04.096. [DOI] [PubMed] [Google Scholar]

[CR65] 65.Wang M, Hou ZH, Xu H, Liu Y, Budoff MJ, Szpiro AA, et al. Association of Estimated Long-term Exposure to Air Pollution and Traffic Proximity With a Marker for Coronary Atherosclerosis in a Nationwide Study in China. JAMA Net Open. 2019;2(6):e196553. doi: 10.1001/jamanetworkopen.2019.6553. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR66] 66.Su TC, Hwang JJ, Shen YC, Chan CC. Carotid Intima-Media Thickness and Long-Term Exposure to Traffic-Related Air Pollution in Middle-Aged Residents of Taiwan: A Cross-Sectional Study. Environ Health Perspect. 2015;123(8):773–778. doi: 10.1289/ehp.1408553. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR67] 67.Ramanathan G, Yin F, Speck M, Tseng CH, Brook JR, Silverman F, et al. Effects of urban fine particulate matter and ozone on HDL functionality. Part Fibre Toxicol. 2016;13(1):26. doi: 10.1186/s12989-016-0139-3. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR68] 68.Adar SD, Sheppard L, Vedal S, Polak JF, Sampson PD, Diez Roux AV, et al. Fine particulate air pollution and the progression of carotid intima-medial thickness: a prospective cohort study from the multi-ethnic study of atherosclerosis and air pollution. PLoS Med. 2013;10(4):e1001430. doi: 10.1371/journal.pmed.1001430. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR69] 69.Kim SY, Sheppard L, Kaufman JD, Bergen S, Szpiro AA, Larson TV, et al. Individual-level concentrations of fine particulate matter chemical components and subclinical atherosclerosis: a cross-sectional analysis based on 2 advanced exposure prediction models in the multi-ethnic study of atherosclerosis. Am J Epidemiol. 2014;180(7):718–728. doi: 10.1093/aje/kwu186. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR70] 70.Tonne C, Salmon M, Sanchez M, Sreekanth V, Bhogadi S, Sambandam S, et al. Integrated assessment of exposure to PM2.5 in South India and its relation with cardiovascular risk: Design of the CHAI observational cohort study. Int J Hyg Environ Health. 2017;220(6):1081–1088. doi: 10.1016/j.ijheh.2017.05.005. [DOI] [PubMed] [Google Scholar]

[CR71] 71.Hennig F, Moebus S, Reinsch N, Budde T, Erbel R, Jockel KH, et al. Investigation of air pollution and noise on progression of thoracic aortic calcification: results of the Heinz Nixdorf Recall Study. Eur J Prev Cardiol. 2019:2047487319854818. 10.1177/2047487319854818. [DOI] [PMC free article] [PubMed]

[CR72] 72.Gondalia R, Holliday KM, Baldassari A, Justice AE, Stewart JD, Liao D, et al. Leukocyte Traits and Exposure to Ambient Particulate Matter Air Pollution in the Women's Health Initiative and Atherosclerosis Risk in Communities Study. Environ Health Perspect. 2020;128(1):17004. doi: 10.1289/ehp5360. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR73] 73.Lenters V, Uiterwaal CS, Beelen R, Bots ML, Fischer P, Brunekreef B, et al. Long-term exposure to air pollution and vascular damage in young adults. Epidemiology. 2010;21(4):512–520. doi: 10.1097/EDE.0b013e3181dec3a7. [DOI] [PubMed] [Google Scholar]

[CR74] 74.O'Neill MS, Diez-Roux AV, Auchincloss AH, Shen M, Lima JA, Polak JF, et al. Long-term exposure to airborne particles and arterial stiffness: the Multi-Ethnic Study of Atherosclerosis (MESA) Environ Health Perspect. 2011;119(6):844–851. doi: 10.1289/ehp.0901524. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR75] 75.Huynh Q, Marwick TH, Venkataraman P, Knibbs LD, Johnston FH, Negishi K. Long-term exposure to ambient air pollution is associated with coronary artery calcification among asymptomatic adults. Eur Heart J Cardiovasc Imaging. 2020. 10.1093/ehjci/jeaa073. [DOI] [PubMed]

[CR76] 76.Fuks K, Moebus S, Hertel S, Viehmann A, Nonnemacher M, Dragano N, et al. Long-term urban particulate air pollution, traffic noise, and arterial blood pressure. Environ Health Perspect. 2011;119(12):1706–1711. doi: 10.1289/ehp.1103564. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR77] 77.Aguilera I, Dratva J, Caviezel S, Burdet L, de Groot E, Ducret-Stich RE, et al. Particulate Matter and Subclinical Atherosclerosis: Associations between Different Particle Sizes and Sources with Carotid Intima-Media Thickness in the SAPALDIA Study. Environ Halth Perspect. 2016;124(11):1700–1706. doi: 10.1289/ehp161. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR78] 78.Sun M, Kaufman JD, Kim SY, Larson TV, Gould TR, Polak JF, et al. Particulate matter components and subclinical atherosclerosis: common approaches to estimating exposure in a Multi-Ethnic Study of Atherosclerosis cross-sectional study. Environ Health. 2013;12:39. doi: 10.1186/1476-069x-12-39. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR79] 79.Yang S, Lee SP, Park JB, Lee H, Kang SH, Lee SE, et al. PM2.5 concentration in the ambient air is a risk factor for the development of high-risk coronary plaques. Eur Heart J Cardiovasc Imaging. 2019;20(12):1355–1364. doi: 10.1093/ehjci/jez209. [DOI] [PubMed] [Google Scholar]

[CR80] 80.Duan C, Talbott EO, Broadwin R, Brooks M, Matthews K, Barinas-Mitchell E. Residential Exposure to PM2.5 and Ozone and Progression of Subclinical Atherosclerosis Among Women Transitioning Through Menopause: The Study of Women's Health Across the Nation. J Women's Health. 2019;28(6):802–811. doi: 10.1089/jwh.2018.7182. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR81] 81.Hoffmann B, Moebus S, Mohlenkamp S, Stang A, Lehmann N, Dragano N, et al. Residential exposure to traffic is associated with coronary atherosclerosis. Circulation. 2007;116(5):489–496. doi: 10.1161/circulationaha.107.693622. [DOI] [PubMed] [Google Scholar]

[CR82] 82.Dorans KS, Wilker EH, Li W, Rice MB, Ljungman PL, Schwartz J, et al. Residential proximity to major roads, exposure to fine particulate matter and aortic calcium: the Framingham Heart Study, a cohort study. BMJ Open. 2017;7(3):e013455. doi: 10.1136/bmjopen-2016-013455. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR83] 83.Zhang Z, Chang LY, Lau AKH, Chan TC, Chieh Chuang Y, Chan J, et al. Satellite-based estimates of long-term exposure to fine particulate matter are associated with C-reactive protein in 30 034 Taiwanese adults. Int J Epidemiol. 2017;46(4):1126–1136. doi: 10.1093/ije/dyx069. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR84] 84.Breton CV, Wang X, Mack WJ, Berhane K, Lopez M, Islam TS, et al. Childhood air pollutant exposure and carotid artery intima-media thickness in young adults. Circulation. 2012;126(13):1614–1620. doi: 10.1161/circulationaha.112.096164. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR85] 85.Duan C, Talbott E, Brooks M, Park SK, Broadwin R, Matthews K, et al. Five-year exposure to PM(2.5) and ozone and subclinical atherosclerosis in late midlife women: The Study of Women's Health Across the Nation. Int J Hyg Environ Health. 2019;222(2):168–176. doi: 10.1016/j.ijheh.2018.09.001. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR86] 86.Bauer M, Moebus S, Möhlenkamp S, Dragano N, Nonnemacher M, Fuchsluger M, et al. Urban particulate matter air pollution is associated with subclinical atherosclerosis: results from the HNR (Heinz Nixdorf Recall) study. J Am Coll Cardiol. 2010;56(22):1803–1808. doi: 10.1016/j.jacc.2010.04.065. [DOI] [PubMed] [Google Scholar]

[CR87] 87.Baumgartner J, Carter E, Schauer JJ, Ezzati M, Daskalopoulou SS, Valois MF, et al. Household air pollution and measures of blood pressure, arterial stiffness and central haemodynamics. Heart. 2018;104(18):1515–1521. doi: 10.1136/heartjnl-2017-312595. [DOI] [PubMed] [Google Scholar]

[CR88] 88.Painschab MS, Davila-Roman VG, Gilman RH, Vasquez-Villar AD, Pollard SL, Wise RA, et al. Chronic exposure to biomass fuel is associated with increased carotid artery intima-media thickness and a higher prevalence of atherosclerotic plaque. Heart. 2013;99(14):984–991. doi: 10.1136/heartjnl-2012-303440. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR89] 89.Künzli N, Jerrett M, Mack WJ, Beckerman B, LaBree L, Gilliland F, et al. Ambient air pollution and atherosclerosis in Los Angeles. Environ Health Perspect. 2005;113(2):201–206. doi: 10.1289/ehp.7523. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR90] 90.Allen RW, Criqui MH, Diez Roux AV, Allison M, Shea S, Detrano R, et al. Fine particulate matter air pollution, proximity to traffic, and aortic atherosclerosis. Epidemiology. 2009;20(2):254–264. doi: 10.1097/EDE.0b013e31819644cc. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR91] 91.Diez Roux AV, Auchincloss AH, Franklin TG, Raghunathan T, Barr RG, Kaufman J, et al. Long-term exposure to ambient particulate matter and prevalence of subclinical atherosclerosis in the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol. 2008;167(6):667–675. doi: 10.1093/aje/kwm359. [DOI] [PubMed] [Google Scholar]

[CR92] 92.Pang Y, Zhang B, Xing D, Shang J, Chen F, Kang H, et al. Increased risk of carotid atherosclerosis for long-term exposure to indoor coal-burning pollution in rural area, Hebei Province, China. Environ Pollut. 2019;255(Pt 2):113320. doi: 10.1016/j.envpol.2019.113320. [DOI] [PubMed] [Google Scholar]

[CR93] 93.Lee SH, Kim JH, Kang MJ, Lee YA, Won Yang S, Shin CH. Implications of nocturnal hypertension in children and adolescents with type 1 diabetes. Diabetes Care. 2011;34(10):2180–2185. doi: 10.2337/dc11-0830. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR94] 94.Du X, Jiang S, Zeng X, Zhang J, Pan K, Zhou J, et al. Air pollution is associated with the development of atherosclerosis via the cooperation of CD36 and NLRP3 inflammasome in ApoE(-/-) mice. Toxicol Lett. 2018;290:123–132. doi: 10.1016/j.toxlet.2018.03.022. [DOI] [PubMed] [Google Scholar]

[CR95] 95.Wan Q, Liu Z, Yang M, Wu J. Acceleratory effects of ambient fine particulate matter on the development and progression of atherosclerosis in apolipoprotein E knockout mice by down-regulating CD4(+)CD25(+)Foxp3(+) regulatory T cells. Toxicol Lett. 2019;316:27–34. doi: 10.1016/j.toxlet.2019.09.005. [DOI] [PubMed] [Google Scholar]

[CR96] 96.Wan Q, Cui X, Shao J, Zhou F, Jia Y, Sun X, et al. Beijing ambient particle exposure accelerates atherosclerosis in ApoE knockout mice by upregulating visfatin expression. Cell Stress Chaperones. 2014;19(5):715–724. doi: 10.1007/s12192-014-0499-2. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR97] 97.Chen T, Jia G, Wei Y, Li J. Beijing ambient particle exposure accelerates atherosclerosis in ApoE knockout mice. Toxicol Lett. 2013;223(2):146–153. doi: 10.1016/j.toxlet.2013.09.004. [DOI] [PubMed] [Google Scholar]

[CR98] 98.Zhao J, Mi X, Zhao L, Midgley AC, Tang H, Tian M, et al. Validation of PM(2.5) model particle through physicochemical evaluation and atherosclerotic plaque formation in ApoE(-/-) mice. Ecotoxicol Environ Saf. 2020;192:110308. doi: 10.1016/j.ecoenv.2020.110308. [DOI] [PubMed] [Google Scholar]

[CR99] 99.Quan C, Sun Q, Lippmann M, Chen LC. Comparative effects of inhaled diesel exhaust and ambient fine particles on inflammation, atherosclerosis, and vascular dysfunction. Inhal Toxicol. 2010;22(9):738–753. doi: 10.3109/08958371003728057. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR100] 100.Wang S, Wang F, Yang L, Li Q, Huang Y, Cheng Z, et al. Effects of coal-fired PM(2.5) on the expression levels of atherosclerosis-related proteins and the phosphorylation level of MAPK in ApoE(-/-) mice. BMC Pharmacol Toxicol. 2020;21(1):34. doi: 10.1186/s40360-020-00411-8. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR101] 101.Sun Q, Wang A, Jin X, Natanzon A, Duquaine D, Brook RD, et al. Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model. Jama. 2005;294(23):3003–3010. doi: 10.1001/jama.294.23.3003. [DOI] [PubMed] [Google Scholar]

[CR102] 102.Araujo JA, Barajas B, Kleinman M, Wang X, Bennett BJ, Gong KW, et al. Ambient particulate pollutants in the ultrafine range promote early atherosclerosis and systemic oxidative stress. Circ Res. 2008;102(5):589–596. doi: 10.1161/circresaha.107.164970. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR103] 103.Chen LC, Nadziejko C. Effects of subchronic exposures to concentrated ambient particles (CAPs) in mice. V. CAPs exacerbate aortic plaque development in hyperlipidemic mice. Inhal Toxicol. 2005;17(4-5):217–224. doi: 10.1080/08958370590912815. [DOI] [PubMed] [Google Scholar]

[CR104] 104.Zhu X, Zhao P, Lu Y, Huo L, Bai M, Yu F, et al. Potential injurious effects of the fine particulate PM2.5 on the progression of atherosclerosis in apoE-deficient mice by activating platelets and leukocytes. Arch Med Sci. 2019;15(1):250–261. doi: 10.5114/aoms.2018.81039. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR105] 105.Bai Y, Sun Q. Fine particulate matter air pollution and atherosclerosis: Mechanistic insights. Biochim Biophys Acta. 2016;1860(12):2863–2868. doi: 10.1016/j.bbagen.2016.04.030. [DOI] [PubMed] [Google Scholar]

[CR106] 106.Grahame TJ, Schlesinger RB. Oxidative stress-induced telomeric erosion as a mechanism underlying airborne particulate matter-related cardiovascular disease. Part Fibre Toxicol. 2012;9:21. doi: 10.1186/1743-8977-9-21. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR107] 107.Bourdrel T, Bind MA, Béjot Y, Morel O, Argacha JF. Cardiovascular effects of air pollution. Arch Cardiovasc Dis. 2017;110(11):634–642. doi: 10.1016/j.acvd.2017.05.003. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR108] 108.Dai J, Chen W, Lin Y, Wang S, Guo X, Zhang QQ. Exposure to Concentrated Ambient Fine Particulate Matter Induces Vascular Endothelial Dysfunction via miR-21. Int J Biol Sci. 2017;13(7):868–877. doi: 10.7150/ijbs.19868. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR109] 109.Guo S, Som AT, Arai K, Lo EH. Effects of angiotensin-II on brain endothelial cell permeability via PPARalpha regulation of para- and trans-cellular pathways. Brain Res. 2019;1722:146353. doi: 10.1016/j.brainres.2019.146353. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR110] 110.Han W, Dan W, Shuo Y, Fang Z, Wenjun D. Oxidative stress induced by urban fine particles in cultured EA.hy926 cells. Hum Exp Toxicol. 2011;30(7):579–590. doi: 10.1177/0960327110374207. [DOI] [PubMed] [Google Scholar]

[CR111] 111.Wang Y, Tang M. PM2.5 induces autophagy and apoptosis through endoplasmic reticulum stress in human endothelial cells. Sci Total Environ. 2020;710:136397. doi: 10.1016/j.scitotenv.2019.136397. [DOI] [PubMed] [Google Scholar]

[CR112] 112.Wang Y, Tang M. PM2.5 induces ferroptosis in human endothelial cells through iron overload and redox imbalance. Environ Pollut. 2019;254(Pt A):112937. doi: 10.1016/j.envpol.2019.07.105. [DOI] [PubMed] [Google Scholar]

[CR113] 113.Sharma K, Lee HH, Gong DS, Park SH, Yi E, Schini-Kerth V, et al. Fine air pollution particles induce endothelial senescence via redox-sensitive activation of local angiotensin system. Environ Pollut. 2019;252(Pt A):317–329. doi: 10.1016/j.envpol.2019.05.066. [DOI] [PubMed] [Google Scholar]

[CR114] 114.Long YM, Yang XZ, Yang QQ, Clermont AC, Yin YG, Liu GL, et al. PM2.5 induces vascular permeability increase through activating MAPK/ERK signaling pathway and ROS generation. J Hazard Mater. 2020;386:121659. doi: 10.1016/j.jhazmat.2019.121659. [DOI] [PubMed] [Google Scholar]

[CR115] 115.Montiel-Dávalos A, Ibarra-Sánchez Mde J, Ventura-Gallegos JL, Alfaro-Moreno E, López-Marure R. Oxidative stress and apoptosis are induced in human endothelial cells exposed to urban particulate matter. Toxicol in Vitro. 2010;24(1):135–141. doi: 10.1016/j.tiv.2009.08.004. [DOI] [PubMed] [Google Scholar]

[CR116] 116.Xu X, Xu H, Qimuge A, Liu S, Wang H, Hu M, et al. MAPK/AP-1 pathway activation mediates AT1R upregulation and vascular endothelial cells dysfunction under PM2.5 exposure. Ecotoxicol Environ Saf. 2019;170:188–194. doi: 10.1016/j.ecoenv.2018.11.124. [DOI] [PubMed] [Google Scholar]

[CR117] 117.Chen S, Wu X, Hu J, Dai G, Rong A, Guo G. PM2.5 exposure decreases viability, migration and angiogenesis in human umbilical vein endothelial cells and human microvascular endothelial cells. Mol Med Rep. 2017;16 3:2425-2430; doi: 10.3892/mmr.2017.6877. [DOI] [PMC free article] [PubMed]

[CR118] 118.Rui W, Guan L, Zhang F, Zhang W, Ding W. PM2.5-induced oxidative stress increases adhesion molecules expression in human endothelial cells through the ERK/AKT/NF-kappaB-dependent pathway. J Appl Toxicol. 2016;36(1):48–59. doi: 10.1002/jat.3143. [DOI] [PubMed] [Google Scholar]

[CR119] 119.Zhu F, Cheng H, Lei R, Shen C, Liu J, Hou L, et al. Effects of cooking oil fume derived fine particulate matter on blood vessel formation through the VEGF/VEGFR2/MEK1/2/ERK1/2/mTOR pathway in human umbilical vein endothelial cells. Environ Toxicol Pharmacol. 2019;69:112–119. doi: 10.1016/j.etap.2019.04.008. [DOI] [PubMed] [Google Scholar]

[CR120] 120.Le Y, Hu X, Zhu J, Wang C, Yang Z, Lu D. Ambient fine particulate matter induces inflammatory responses of vascular endothelial cells through activating TLR-mediated pathway. Toxicol Ind Health. 2019;35(10):670–678. doi: 10.1177/0748233719871778. [DOI] [PubMed] [Google Scholar]

[CR121] 121.Yin J, Xia W, Li Y, Guo C, Zhang Y, Huang S, et al. COX-2 mediates PM2.5-induced apoptosis and inflammation in vascular endothelial cells. Am J Transl Res. 2017;9(9):3967–3976. [PMC free article] [PubMed] [Google Scholar]

[CR122] 122.Wang JS, Tseng CY, Chao MW. Diesel Exhaust Particles Contribute to Endothelia Apoptosis via Autophagy Pathway. Toxicol Sci. 2017;156(1):72–83. doi: 10.1093/toxsci/kfw237. [DOI] [PubMed] [Google Scholar]

[CR123] 123.Li R, Ning Z, Cui J, Yu F, Sioutas C, Hsiai T. Diesel exhaust particles modulate vascular endothelial cell permeability: implication of ZO-1 expression. Toxicol Lett. 2010;197(3):163–168. doi: 10.1016/j.toxlet.2010.05.017. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR124] 124.Zhao J, Xie Y, Jiang R, Kan H, Song W. Effects of atorvastatin on fine particle-induced inflammatory response, oxidative stress and endothelial function in human umbilical vein endothelial cells. Hum Exp Toxicol. 2011;30(11):1828–1839. doi: 10.1177/0960327111401050. [DOI] [PubMed] [Google Scholar]

[CR125] 125.Lai CY, Lai CH, Chuang HC, Pan CH, Yen CC, Lin WY, et al. Physicochemistry and cardiovascular toxicity of metal fume PM2.5: a study of human coronary artery endothelial cells and welding workers. Sci Rep. 2016;6:33515. doi: 10.1038/srep33515. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR126] 126.Montiel-Dávalos A, Alfaro-Moreno E, López-Marure R. PM2.5 and PM10 induce the expression of adhesion molecules and the adhesion of monocytic cells to human umbilical vein endothelial cells. Inhal Toxicol. 2007;19(Suppl 1):91–98. doi: 10.1080/08958370701495212. [DOI] [PubMed] [Google Scholar]

[CR127] 127.Zhou Z, Shao T, Qin M, Miao X, Chang Y, Sheng W, et al. The effects of autophagy on vascular endothelial cells induced by airborne PM2.5. J Environ Sci. 2018;66:182–187. doi: 10.1016/j.jes.2017.05.019. [DOI] [PubMed] [Google Scholar]

[CR128] 128.Wang FF, Geng CM, Hao WD, Zhao YD, Li Q, Wang HM, et al. The Cellular Toxicity of PM2.5 Emitted from Coal Combustion in Human Umbilical Vein Endothelial Cells. Biomed Environ Sci. 2016;29(2):107–116. doi: 10.3967/bes2016.012. [DOI] [PubMed] [Google Scholar]

[CR129] 129.Wu S, Wang B, Yang D, Wei H, Li H, Pan L, et al. Ambient particulate air pollution and circulating antioxidant enzymes: A repeated-measure study in healthy adults in Beijing, China. Environ Pollut. 2016;208(Pt A):16–24. doi: 10.1016/j.envpol.2015.06.002. [DOI] [PubMed] [Google Scholar]

[CR130] 130.Feng B, Qi R, Gao J, Wang T, Xu H, Zhao Q, et al. Exercise training prevented endothelium dysfunction from particulate matter instillation in Wistar rats. Sci Total Environ. 2019;694:133674. doi: 10.1016/j.scitotenv.2019.133674. [DOI] [PubMed] [Google Scholar]

[CR131] 131.Kattoor AJ, Pothineni NVK, Palagiri D, Mehta JL. Oxidative Stress in Atherosclerosis. Curr Atheroscler Rep. 2017;19(11):42. doi: 10.1007/s11883-017-0678-6. [DOI] [PubMed] [Google Scholar]

[CR132] 132.Miao X, Li W, Niu B, Li J, Sun J, Qin M, et al. Mitochondrial dysfunction in endothelial cells induced by airborne fine particulate matter (<2.5 mum) J Appl Toxicol. 2019;39(10):1424–1432. doi: 10.1002/jat.3828. [DOI] [PubMed] [Google Scholar]

[CR133] 133.Kim D, Mouritzen U, Larsen BD, Roy S. Inhibition of Cx43 gap junction uncoupling prevents high glucose-induced apoptosis and reduces excess cell monolayer permeability in retinal vascular endothelial cells. Exp Eye Res. 2018;173:85–90. doi: 10.1016/j.exer.2018.05.003. [DOI] [PubMed] [Google Scholar]

[CR134] 134.Hennig B, Chow CK. Lipid peroxidation and endothelial cell injury: implications in atherosclerosis. Free Radic Biol Med. 1988;4(2):99–106. doi: 10.1016/0891-5849(88)90070-6. [DOI] [PubMed] [Google Scholar]

[CR135] 135.Krouwer VJ, Hekking LH, Langelaar-Makkinje M, Regan-Klapisz E, Post JA. Endothelial cell senescence is associated with disrupted cell-cell junctions and increased monolayer permeability. Vasc Cell. 2012;4(1):12. doi: 10.1186/2045-824x-4-12. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR136] 136.Grimsley-Myers CM, Isaacson RH, Cadwell CM, Campos J, Hernandes MS, Myers KR, et al. VE-cadherin endocytosis controls vascular integrity and patterning during development. J Cell Biol. 2020;219:5. doi: 10.1083/jcb.201909081. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR137] 137.Wang T, Shimizu Y, Wu X, Kelly GT, Xu X, Wang L, et al. Particulate matter disrupts human lung endothelial cell barrier integrity via Rho-dependent pathways. Pulm Circ. 2017;7(3):617–623. doi: 10.1086/689906. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR138] 138.Giannotta M, Trani M, Dejana E. VE-cadherin and endothelial adherens junctions: active guardians of vascular integrity. Dev Cell. 2013;26(5):441–454. doi: 10.1016/j.devcel.2013.08.020. [DOI] [PubMed] [Google Scholar]

[CR139] 139.Marasciulo FL, Montagnani M, Potenza MA. Endothelin-1: the yin and yang on vascular function. Curr Med Chem. 2006;13(14):1655–1665. doi: 10.2174/092986706777441968. [DOI] [PubMed] [Google Scholar]

[CR140] 140.Niu J, Wu J, Li X, Zhang F. Association between endothelin-1/endothelin receptor A and inflammation in mouse kidneys following acute ischemia/reperfusion. Mol Med Rep. 2015;11(5):3981–3987. doi: 10.3892/mmr.2014.3138. [DOI] [PubMed] [Google Scholar]

[CR141] 141.Mazzuca MQ, Khalil RA. Vascular endothelin receptor type B: structure, function and dysregulation in vascular disease. Biochem Pharmacol. 2012;84(2):147–162. doi: 10.1016/j.bcp.2012.03.020. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR142] 142.Gimbrone MA, Jr, Garcia-Cardena G. Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis. Circ Res. 2016;118(4):620–636. doi: 10.1161/circresaha.115.306301. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR143] 143.Deweirdt J, Quignard JF, Crobeddu B, Baeza-Squiban A, Sciare J, Courtois A, et al. Involvement of oxidative stress and calcium signaling in airborne particulate matter - induced damages in human pulmonary artery endothelial cells. Toxicol in Vitro. 2017;45(Pt 3):340–350. doi: 10.1016/j.tiv.2017.07.001. [DOI] [PubMed] [Google Scholar]

[CR144] 144.Xiao X, Cao L, Wang R, Shen ZX, Cao YX. Airborne fine particulate matter alters the expression of endothelin receptors in rat coronary arteries. Environ Pollut. 2016;218:487–496. doi: 10.1016/j.envpol.2016.07.028. [DOI] [PubMed] [Google Scholar]

[CR145] 145.Chan EA, Buckley B, Farraj AK, Thompson LC. The heart as an extravascular target of endothelin-1 in particulate matter-induced cardiac dysfunction. Pharmacol Ther. 2016;165:63–78. doi: 10.1016/j.pharmthera.2016.05.006. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR146] 146.Lin YJ, Kwok CF, Juan CC, Hsu YP, Shih KC, Chen CC, et al. Angiotensin II enhances endothelin-1-induced vasoconstriction through upregulating endothelin type A receptor. Biochem Biophys Res Commun. 2014;451(2):263–269. doi: 10.1016/j.bbrc.2014.07.119. [DOI] [PubMed] [Google Scholar]

[CR147] 147.Haberzettl P, O'Toole TE, Bhatnagar A, Conklin DJ. Exposure to Fine Particulate Air Pollution Causes Vascular Insulin Resistance by Inducing Pulmonary Oxidative Stress. Environ Health Perspect. 2016;124(12):1830–1839. doi: 10.1289/ehp212. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR148] 148.Kim F, Pham M, Maloney E, Rizzo NO, Morton GJ, Wisse BE, et al. Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance. Arterioscler Thromb Vasc Biol. 2008;28(11):1982–1988. doi: 10.1161/atvbaha.108.169722. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR149] 149.Kim JA, Montagnani M, Koh KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation. 2006;113(15):1888–1904. doi: 10.1161/circulationaha.105.563213. [DOI] [PubMed] [Google Scholar]

[CR150] 150.Landmesser U, Hornig B, Drexler H. Endothelial function: a critical determinant in atherosclerosis? Circulation. 2004;109(21 Suppl 1):Ii27–Ii33. doi: 10.1161/01.CIR.0000129501.88485.1f. [DOI] [PubMed] [Google Scholar]

[CR151] 151.Bayraktutan U. Endothelial progenitor cells: Potential novel therapeutics for ischaemic stroke. Pharmacol Res. 2019;144:181–191. doi: 10.1016/j.phrs.2019.04.017. [DOI] [PubMed] [Google Scholar]

[CR152] 152.Noor R, Shuaib U, Wang CX, Todd K, Ghani U, Schwindt B, et al. High-density lipoprotein cholesterol regulates endothelial progenitor cells by increasing eNOS and preventing apoptosis. Atherosclerosis. 2007;192(1):92–99. doi: 10.1016/j.atherosclerosis.2006.06.023. [DOI] [PubMed] [Google Scholar]

[CR153] 153.Haberzettl P, Conklin DJ, Abplanalp WT, Bhatnagar A, O'Toole TE. Inhalation of Fine Particulate Matter Impairs Endothelial Progenitor Cell Function Via Pulmonary Oxidative Stress. Arterioscler Thromb Vasc Biol. 2018;38(1):131–142. doi: 10.1161/atvbaha.117.309971. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR154] 154.Haberzettl P, McCracken JP, Bhatnagar A, Conklin DJ. Insulin sensitizers prevent fine particulate matter-induced vascular insulin resistance and changes in endothelial progenitor cell homeostasis. Am J Physiol Heart Circ Physiol. 2016;310(11):H1423–H1438. doi: 10.1152/ajpheart.00369.2015. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR155] 155.Cui Y, Sun Q, Liu Z. Ambient particulate matter exposure and cardiovascular diseases: a focus on progenitor and stem cells. J Cell Mol Med. 2016;20(5):782–793. doi: 10.1111/jcmm.12822. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR156] 156.Jian D, Wang W, Zhou X, Jia Z, Wang J, Yang M, et al. Interferon-induced protein 35 inhibits endothelial cell proliferation, migration and re-endothelialization of injured arteries by inhibiting the nuclear factor-kappa B pathway. Acta Physiol (Ox) 2018;223(3):e13037. doi: 10.1111/apha.13037. [DOI] [PubMed] [Google Scholar]

[CR157] 157.Robertson S, Miller MR. Ambient air pollution and thrombosis. Part Fibre Toxicol. 2018;15(1):1. doi: 10.1186/s12989-017-0237-x. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR158] 158.Esmon CT. Coagulation inhibitors in inflammation. Biochem Soc Trans. 2005;33(Pt 2):401–405. doi: 10.1042/bst0330401. [DOI] [PubMed] [Google Scholar]

[CR159] 159.Hu H, Wu J, Li Q, Asweto C, Feng L, Yang X, et al. Fine particulate matter induces vascular endothelial activation via IL-6 dependent JAK1/STAT3 signaling pathway. Toxicol Res. 2016;5(3):946–953. doi: 10.1039/c5tx00351b. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR160] 160.Liang S, Zhao T, Hu H, Shi Y, Xu Q, Miller MR, et al. Repeat dose exposure of PM2.5 triggers the disseminated intravascular coagulation (DIC) in SD rats. Sci Total Environ. 2019;663:245–253. doi: 10.1016/j.scitotenv.2019.01.346. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR161] 161.Kawecki C, Lenting PJ, Denis CV. von Willebrand factor and inflammation. J Thromb Haemost. 2017;15(7):1285–1294. doi: 10.1111/jth.13696. [DOI] [PubMed] [Google Scholar]

[CR162] 162.Lordan R, Tsoupras A, Zabetakis I. Platelet activation and prothrombotic mediators at the nexus of inflammation and atherosclerosis: Potential role of antiplatelet agents. Blood Rev. 2020;100694. 10.1016/j.blre.2020.100694. [DOI] [PubMed]

[CR163] 163.Ten Cate H, Hackeng TM, Garcia de Frutos P. Coagulation factor and protease pathways in thrombosis and cardiovascular disease. Thromb Haemost. 2017;117(7):1265–1271. doi: 10.1160/th17-02-0079. [DOI] [PubMed] [Google Scholar]

[CR164] 164.Liu C, Cai J, Qiao L, Wang H, Xu W, Li H, et al. The Acute Effects of Fine Particulate Matter Constituents on Blood Inflammation and Coagulation. Environ Sci Technol. 2017;51(14):8128–8137. doi: 10.1021/acs.est.7b00312. [DOI] [PubMed] [Google Scholar]

[CR165] 165.Libby P, Buring JE, Badimon L, Hansson GK, Deanfield J, Bittencourt MS, et al. Atherosclerosis. Nature reviews Disease primers. 2019;5 1:56; doi: 10.1038/s41572-019-0106-z. [DOI] [PubMed]

[CR166] 166.Tabas I, Bornfeldt KE. Intracellular and Intercellular Aspects of Macrophage Immunometabolism in Atherosclerosis. Circ Res. 2020;126(9):1209–1227. doi: 10.1161/circresaha.119.315939. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR167] 167.Goldberg AC, Leiter LA, Stroes ESG, Baum SJ, Hanselman JC, Bloedon LT, et al. Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease: The CLEAR Wisdom Randomized Clinical Trial. Jama. 2019;322(18):1780–1788. doi: 10.1001/jama.2019.16585. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR168] 168.Hansson GK, Jonasson L. The discovery of cellular immunity in the atherosclerotic plaque. Arterioscler Thromb Vasc Biol. 2009;29(11):1714–1717. doi: 10.1161/atvbaha.108.179713. [DOI] [PubMed] [Google Scholar]

[CR169] 169.Huang L, Chambliss KL, Gao X, Yuhanna IS, Behling-Kelly E, Bergaya S, et al. SR-B1 drives endothelial cell LDL transcytosis via DOCK4 to promote atherosclerosis. Nature. 2019;569(7757):565–569. doi: 10.1038/s41586-019-1140-4. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR170] 170.Mehta JL, Chen J, Hermonat PL, Romeo F, Novelli G. Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders. Cardiovasc Res. 2006;69(1):36–45. doi: 10.1016/j.cardiores.2005.09.006. [DOI] [PubMed] [Google Scholar]

[CR171] 171.Li D, Mehta JL. Intracellular signaling of LOX-1 in endothelial cell apoptosis. Circ Res. 2009;104(5):566–568. doi: 10.1161/circresaha.109.194209. [DOI] [PubMed] [Google Scholar]

[CR172] 172.Akhmedov A, Rozenberg I, Paneni F, Camici GG, Shi Y, Doerries C, et al. Endothelial overexpression of LOX-1 increases plaque formation and promotes atherosclerosis in vivo. Eur Heart J. 2014;35(40):2839–2848. doi: 10.1093/eurheartj/eht532. [DOI] [PubMed] [Google Scholar]

[CR173] 173.Markstad H, Edsfeldt A, Yao Mattison I, Bengtsson E, Singh P, Cavalera M, et al. High Levels of Soluble Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 Are Associated With Carotid Plaque Inflammation and Increased Risk of Ischemic Stroke. J Ame Heart Assoc. 2019;8(4):e009874. doi: 10.1161/JAHA.118.009874. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR174] 174.Lund AK, Lucero J, Harman M, Madden MC, McDonald JD, Seagrave JC, et al. The oxidized low-density lipoprotein receptor mediates vascular effects of inhaled vehicle emissions. Am J Respir Crit Care Med. 2011;184(1):82–91. doi: 10.1164/rccm.201012-1967OC. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR175] 175.Kodavanti UP, Thomas R, Ledbetter AD, Schladweiler MC, Shannahan JH, Wallenborn JG, et al. Vascular and cardiac impairments in rats inhaling ozone and diesel exhaust particles. Environ Health Perspect. 2011;119(3):312–318. doi: 10.1289/ehp.1002386. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR176] 176.Lucero J, Suwannasual U, Herbert LM, McDonald JD, Lund AK. The role of the lectin-like oxLDL receptor (LOX-1) in traffic-generated air pollution exposure-mediated alteration of the brain microvasculature in Apolipoprotein (Apo) E knockout mice. Inhal Toxicol. 2017;29(6):266–281. doi: 10.1080/08958378.2017.1357774. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR177] 177.Liu J, Liang S, Du Z, Zhang J, Sun B, Zhao T, et al. PM2.5 aggravates the lipid accumulation, mitochondrial damage and apoptosis in macrophage foam cells. Environ Pollut. 2019;249:482–490. doi: 10.1016/j.envpol.2019.03.045. [DOI] [PubMed] [Google Scholar]

[CR178] 178.WHO, Burden of disease from the joint effects of household and ambient air pollution. 2018, Available from: www.who.int/airpollution/data/.

[CR179] 179.Brauner EV, Forchhammer L, Moller P, Barregard L, Gunnarsen L, Afshari A, et al. Indoor particles affect vascular function in the aged: an air filtration-based intervention study. Am J Respir Crit Care Med. 2008;177(4):419–425. doi: 10.1164/rccm.200704-632OC. [DOI] [PubMed] [Google Scholar]

[CR180] 180.Ding R, Zhang C, Zhu X, Cheng H, Zhu F, Xu Y, et al. ROS-AKT-mTOR axis mediates autophagy of human umbilical vein endothelial cells induced by cooking oil fumes-derived fine particulate matters in vitro. Free Radic Biol Med. 2017;113:452–460. doi: 10.1016/j.freeradbiomed.2017.10.386. [DOI] [PubMed] [Google Scholar]

PERMALINK

The critical role of endothelial function in fine particulate matter-induced atherosclerosis

Shuang Liang

Jingyi Zhang

Ruihong Ning

Zhou Du

Jiangyan Liu

Joe Werelagi Batibawa

Junchao Duan

Zhiwei Sun

Abstract

Background

Fig. 1.

PM2.5 and atherosclerosis

Table 1.

Table 2.

Ambient PM2.5 induces endothelial dysfunction

Table 3.

Ambient PM2.5 increases vascular endothelial permeability

Fig. 2.

Ambient PM2.5 impairs vasomotor function

Ambient PM2.5 suppresses vascular endothelial repair

Ambient PM2.5-triggered endothelial injury and atherosclerosis

Ambient PM2.5 causes a pro-coagulant state

Ambient PM2.5 induces an inflammatory response

Ambient PM2.5 promotes lipid deposition

Indoor PM2.5 elicits endothelial dysfunction and atherosclerosis

Conclusion

Acknowledgments

Abbreviations

Authors’ contributions

Funding

Availability of data and materials

Ethics approval and consent to participate

Consent for publication

Competing interests

Footnotes

Contributor Information

References

Associated Data

Data Availability Statement

ACTIONS

PERMALINK

RESOURCES

Similar articles

Cited by other articles

Links to NCBI Databases

PM_2.5 and atherosclerosis

Ambient PM_2.5 induces endothelial dysfunction

Ambient PM_2.5 increases vascular endothelial permeability

Ambient PM_2.5 impairs vasomotor function

Ambient PM_2.5 suppresses vascular endothelial repair

Ambient PM_2.5-triggered endothelial injury and atherosclerosis

Ambient PM_2.5 causes a pro-coagulant state

Ambient PM_2.5 induces an inflammatory response

Ambient PM_2.5 promotes lipid deposition

Indoor PM_2.5 elicits endothelial dysfunction and atherosclerosis